BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy12782
(203 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 121 bits (304), Expect = 3e-28, Method: Composition-based stats.
Identities = 64/167 (38%), Positives = 92/167 (55%), Gaps = 12/167 (7%)
Query: 31 FGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXX 90
FGV++I +H +K YD+A+L+L+ V Y PICLP KG+
Sbjct: 461 FGVQEIIIHDQYKMAESG--YDIALLKLETTVNYTDSQRPICLPSKGD---RNVIYTDCW 515
Query: 91 XXXXXXSRLRPK---TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSC 147
+LR K TLQ +P++ N +C++ ++ + I +M+CAGYR G KD+C
Sbjct: 516 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICAGYREGGKDAC 571
Query: 148 QGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
+GDSGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 572 KGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 618
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 119 bits (298), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 63/177 (35%), Positives = 92/177 (51%), Gaps = 6/177 (3%)
Query: 18 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 77
++N A FGV++I +H +K YD+A+L+L+ V Y PICLP KG
Sbjct: 61 ILNQAEIKEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPICLPSKG 118
Query: 78 EDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCA 137
+ TLQ +P++ N +C++ ++ + I +M+CA
Sbjct: 119 DRNVIYTDCWVTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICA 174
Query: 138 GYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GYR G KD+C+GDSGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 175 GYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 119 bits (298), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 63/177 (35%), Positives = 92/177 (51%), Gaps = 6/177 (3%)
Query: 18 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 77
++N A FGV++I +H +K YD+A+L+L+ V Y PICLP KG
Sbjct: 61 ILNQAEIAEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPICLPSKG 118
Query: 78 EDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCA 137
+ TLQ +P++ N +C++ ++ + I +M+CA
Sbjct: 119 DRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICA 174
Query: 138 GYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GYR G KD+C+GDSGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 175 GYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 119 bits (298), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 63/177 (35%), Positives = 92/177 (51%), Gaps = 6/177 (3%)
Query: 18 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 77
++N A FGV++I +H +K YD+A+L+L+ V Y PICLP KG
Sbjct: 61 ILNQAEIKEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPICLPSKG 118
Query: 78 EDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCA 137
+ TLQ +P++ N +C++ ++ + I +M+CA
Sbjct: 119 DRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICA 174
Query: 138 GYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GYR G KD+C+GDSGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 175 GYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 119 bits (297), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 61/164 (37%), Positives = 88/164 (53%), Gaps = 6/164 (3%)
Query: 31 FGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXX 90
FGV++I +H +K YD+A+L+L+ V Y PICLP KG+
Sbjct: 74 FGVQEIIIHDQYKMAESG--YDIALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTG 131
Query: 91 XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGD 150
TLQ +P++ N +C++ ++ + I +M+CAGYR G KD+C+GD
Sbjct: 132 WGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICAGYREGGKDACKGD 187
Query: 151 SGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
SGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 188 SGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 116 bits (291), Expect = 7e-27, Method: Compositional matrix adjust.
Identities = 61/164 (37%), Positives = 87/164 (53%), Gaps = 6/164 (3%)
Query: 31 FGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXX 90
FGV++I +H +K YD+A+L+L+ V Y PI LP KGE
Sbjct: 74 FGVQEIIIHDQYKMAESG--YDIALLKLETTVNYTDSQRPISLPSKGERNVIYTDCWVTG 131
Query: 91 XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGD 150
TLQ +P++ N +C++ ++ + I +M+CAGYR G KD+C+GD
Sbjct: 132 WGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICAGYREGGKDACKGD 187
Query: 151 SGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
SGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 188 SGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 115 bits (289), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 62/177 (35%), Positives = 91/177 (51%), Gaps = 6/177 (3%)
Query: 18 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 77
++N A FGV++I +H +K YD+A+L+L+ V Y PI LP KG
Sbjct: 61 ILNQAEIAEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPISLPSKG 118
Query: 78 EDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCA 137
+ TLQ +P++ N +C++ ++ + I +M+CA
Sbjct: 119 DRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICA 174
Query: 138 GYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GYR G KD+C+GDSGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 175 GYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 115 bits (289), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 62/177 (35%), Positives = 91/177 (51%), Gaps = 6/177 (3%)
Query: 18 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 77
++N A FGV++I +H +K YD+A+L+L+ V Y PI LP KG
Sbjct: 61 ILNQAEIAEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPISLPSKG 118
Query: 78 EDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCA 137
+ TLQ +P++ N +C++ ++ + I +M+CA
Sbjct: 119 DRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICA 174
Query: 138 GYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GYR G KD+C+GDSGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 175 GYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 115 bits (288), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 62/177 (35%), Positives = 91/177 (51%), Gaps = 6/177 (3%)
Query: 18 VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG 77
++N A FGV++I +H +K YD+A+L+L+ V Y PI LP KG
Sbjct: 61 ILNQAEIKEDTSFFGVQEIIIHDQYKMAESG--YDIALLKLETTVNYADSQRPISLPSKG 118
Query: 78 EDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCA 137
+ TLQ +P++ N +C++ ++ + I +M+CA
Sbjct: 119 DRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICA 174
Query: 138 GYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GYR G KD+C+GDSGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 175 GYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 115 bits (288), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 60/164 (36%), Positives = 87/164 (53%), Gaps = 6/164 (3%)
Query: 31 FGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXX 90
FGV++I +H +K YD+A+L+L+ V Y PI LP KG+
Sbjct: 74 FGVQEIIIHDQYKMAESG--YDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTG 131
Query: 91 XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGD 150
TLQ +P++ N +C++ ++ + I +M+CAGYR G KD+C+GD
Sbjct: 132 WGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICAGYREGGKDACKGD 187
Query: 151 SGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
SGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 188 SGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 115 bits (287), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 60/164 (36%), Positives = 87/164 (53%), Gaps = 6/164 (3%)
Query: 31 FGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXX 90
FGV++I +H +K YD+A+L+L+ V Y PI LP KG+
Sbjct: 74 FGVQEIIIHDQYKMAESG--YDIALLKLETTVNYTDSQRPISLPSKGDRNVIYTDCWVTG 131
Query: 91 XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGD 150
TLQ +P++ N +C++ ++ + I +M+CAGYR G KD+C+GD
Sbjct: 132 WGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKIT----HKMICAGYREGGKDACKGD 187
Query: 151 SGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
SGGPL + W L+GI S G CAQ+ +PG+Y V VDWI
Sbjct: 188 SGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWI 231
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 113 bits (282), Expect = 9e-26, Method: Compositional matrix adjust.
Identities = 55/162 (33%), Positives = 91/162 (56%), Gaps = 6/162 (3%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
+++I +H +K + +D+A+++L P++Y PI LP KG+
Sbjct: 76 IKEIIIHQNYKVS--EGNHDIALIKLQAPLEYTEFQKPISLPSKGDTSTIYTNCWVTGWG 133
Query: 93 XXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSG 152
LQ V++P++ N +C++ ++ + I M+CAGY+ G KD+C+GDSG
Sbjct: 134 FSKEKGEIQNILQKVNIPLVTNEECQKRYQ----DYKITQRMVCAGYKEGGKDACKGDSG 189
Query: 153 GPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GPL+ + G W L+GI S G CA++ QPG+Y +VA +DWI
Sbjct: 190 GPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI 231
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 112 bits (281), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 62/162 (38%), Positives = 86/162 (53%), Gaps = 8/162 (4%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
V KI +H F + + D+++L+L + + ++API LPE+G
Sbjct: 79 VSKIILHENFDYNLLDN--DISLLKLSGSLTFNDNVAPIALPEQGHTATGDVIVTGWGTT 136
Query: 93 XXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSG 152
+ P LQ V VP++ + C + ++ I D M+CAG G KDSCQGDSG
Sbjct: 137 SEGGNT--PDVLQKVTVPLVSDEDCRADYGAD----EILDSMICAGVPEGGKDSCQGDSG 190
Query: 153 GPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GPL TG +L GIVS GY CA+ G PG+Y V+Y VDWI
Sbjct: 191 GPLAASDTGSTYLAGIVSWGYGCARPGYPGVYTEVSYHVDWI 232
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 112 bits (280), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 55/162 (33%), Positives = 90/162 (55%), Gaps = 6/162 (3%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
+++I +H +K + +D+A+++L P+ Y PI LP KG+
Sbjct: 76 IKEIIIHQNYKVS--EGNHDIALIKLQAPLNYTEFQKPISLPSKGDTSTIYTNCWVTGWG 133
Query: 93 XXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSG 152
LQ V++P++ N +C++ ++ + I M+CAGY+ G KD+C+GDSG
Sbjct: 134 FSKEKGEIQNILQKVNIPLVTNEECQKRYQ----DYKITQRMVCAGYKEGGKDACKGDSG 189
Query: 153 GPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GPL+ + G W L+GI S G CA++ QPG+Y +VA +DWI
Sbjct: 190 GPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWI 231
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 109 bits (272), Expect = 1e-24, Method: Compositional matrix adjust.
Identities = 56/167 (33%), Positives = 84/167 (50%), Gaps = 6/167 (3%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
+ +I ++P++ + D+A++ L+ V Y +I PICLPE+ +
Sbjct: 75 IDQIVINPHY--NKRRKNNDIAMMHLEMKVNYTDYIQPICLPEENQVFPPGRICSIAGWG 132
Query: 93 XXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSG 152
LQ DVP++ N +C++ I + M+CAGY G DSCQGDSG
Sbjct: 133 ALIYQGSTADVLQEADVPLLSNEKCQQQMPEYNIT----ENMVCAGYEAGGVDSCQGDSG 188
Query: 153 GPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
GPLM + RW L G+ S GY CA +PG+Y RV +WI ++
Sbjct: 189 GPLMCQENNRWLLAGVTSFGYQCALPNRPGVYARVPRFTEWIQSFLH 235
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 107 bits (268), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 6/167 (3%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
+ +I ++P++ + + D+A++ L+ V Y +I PI LPE+ +
Sbjct: 75 IDEIVINPHYNRRRKDN--DIAMMHLEFKVNYTDYIQPISLPEENQVFPPGRNCSIAGWG 132
Query: 93 XXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSG 152
LQ DVP++ N +C++ I + M+CAGY G DSCQGDSG
Sbjct: 133 TVVYQGTTADILQEADVPLLSNERCQQQMPEYNIT----ENMICAGYEEGGIDSCQGDSG 188
Query: 153 GPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
GPLM + RWFL G+ S GY CA +PG+Y RV+ +WI ++
Sbjct: 189 GPLMCQENNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQSFLH 235
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 105 bits (262), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 56/160 (35%), Positives = 82/160 (51%), Gaps = 3/160 (1%)
Query: 44 FTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKT 103
+ P +D+A+LRL +PV H+ P+CLPE+ R T
Sbjct: 82 YVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGAT 141
Query: 104 ---LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
LQ ++VP + + C + + G + I + M CAGY G+KDSC+GDSGGP
Sbjct: 142 ALVLQVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYR 201
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
G W+L GIVS G CA G G+Y RV+ ++W+ +M +
Sbjct: 202 GTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRS 241
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 105 bits (261), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 67/188 (35%), Positives = 92/188 (48%), Gaps = 9/188 (4%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 68
++ V G+Y EP +R I H Y T +D+A+L LD P+ ++
Sbjct: 48 KITVVAGEYNTEET-EPTEQRRNVIRAIPHHSY-NATVNKYSHDIALLELDEPLTLNSYV 105
Query: 69 APICLPEKG-EDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKSNGI 126
PIC+ +K + +R R T LQ + VP++D C R K
Sbjct: 106 TPICIADKEYTNIFLKFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRSTK---- 161
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
IY M CAG+ G KDSCQGDSGGP + E G FL GI+S G CA +G+ GIY +
Sbjct: 162 -FTIYSNMFCAGFHEGGKDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAVKGKYGIYTK 220
Query: 187 VAYTVDWI 194
V+ V+WI
Sbjct: 221 VSRYVNWI 228
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 103 bits (257), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 55/160 (34%), Positives = 81/160 (50%), Gaps = 3/160 (1%)
Query: 44 FTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKT 103
+ P +D+A+LRL +PV H+ P+CLPE+ R T
Sbjct: 82 YVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGAT 141
Query: 104 ---LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
L ++VP + + C + + G + I + M CAGY G+KDSC+GDSGGP
Sbjct: 142 ALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYR 201
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
G W+L GIVS G CA G G+Y RV+ ++W+ +M +
Sbjct: 202 GTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRS 241
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 103 bits (256), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 64/197 (32%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+A E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTAAEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKS 123
++AP CLPE+ E + R T L+ ++VP +D C+
Sbjct: 103 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL---- 158
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGI 183
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+ GI
Sbjct: 159 -SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGI 217
Query: 184 YHRVAYTVDWISYIMNT 200
Y +V + WI M T
Sbjct: 218 YTKVTAFLKWIDRSMKT 234
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 101 bits (251), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+PG Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKPGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 100 bits (250), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 54/172 (31%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 93 XXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GGAKDSCQG 149
+ +P LQ V++PI++ C+ + + I D M CAGY+ G D+C+G
Sbjct: 140 GWGNLKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDEGKRGDACEG 194
Query: 150 DSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
DSGGP +M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 195 DSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 246
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 100 bits (250), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 62 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 117
Query: 67 HIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKS 123
++AP CLPE+ E + R T L+ ++VP +D C+
Sbjct: 118 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL---- 173
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGI 183
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+ GI
Sbjct: 174 -SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGI 232
Query: 184 YHRVAYTVDWISYIMNT 200
Y +V + WI M T
Sbjct: 233 YTKVTAFLKWIDRSMKT 249
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 100 bits (249), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 56/181 (30%), Positives = 92/181 (50%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G CA++G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCARKGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 100 bits (249), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 58/166 (34%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 36 INVHPYFKFTPQADRY--DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXX 93
I + P+ + ++Y D+A+L LD P+ ++ PIC+ +K
Sbjct: 71 IRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADK---EYTNIFLKFGSGYV 127
Query: 94 XXXSRLRPK-----TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQ 148
R+ K LQ + VP++D C R K IY+ M CAG+ G +DSCQ
Sbjct: 128 SGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTK-----FTIYNNMFCAGFHEGGRDSCQ 182
Query: 149 GDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GDSGGP + E G FL GI+S G CA +G+ GIY +V+ V+WI
Sbjct: 183 GDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 100 bits (249), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKS 123
++AP CLPE+ E + R T L+ ++VP +D C+
Sbjct: 103 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL---- 158
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGI 183
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+ GI
Sbjct: 159 -SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGI 217
Query: 184 YHRVAYTVDWISYIMNT 200
Y +V + WI M T
Sbjct: 218 YTKVTAFLKWIDRSMKT 234
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 100 bits (249), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKS 123
++AP CLPE+ E + R T L+ ++VP +D C+
Sbjct: 103 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL---- 158
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGI 183
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+ GI
Sbjct: 159 -SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGI 217
Query: 184 YHRVAYTVDWISYIMNT 200
Y +V + WI M T
Sbjct: 218 YTKVTAFLKWIDRSMKT 234
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 100 bits (248), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKS 123
++AP CLPE+ E + R T L+ ++VP +D C+
Sbjct: 103 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL---- 158
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGI 183
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+ GI
Sbjct: 159 -SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGI 217
Query: 184 YHRVAYTVDWISYIMNT 200
Y +V + WI M T
Sbjct: 218 YTKVTAFLKWIDRSMKT 234
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 100 bits (248), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKS 123
++AP CLPE+ E + R T L+ ++VP +D C+
Sbjct: 103 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL---- 158
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGI 183
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+ GI
Sbjct: 159 -SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGI 217
Query: 184 YHRVAYTVDWISYIMNT 200
Y +V + WI M T
Sbjct: 218 YTKVTAFLKWIDRSMKT 234
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 100 bits (248), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKS 123
++AP CLPE+ E + R T L+ ++VP +D C+
Sbjct: 103 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL---- 158
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGI 183
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+ GI
Sbjct: 159 -SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGI 217
Query: 184 YHRVAYTVDWISYIMNT 200
Y +V + WI M T
Sbjct: 218 YTKVTAFLKWIDRSMKT 234
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 100 bits (248), Expect = 7e-22, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKS 123
++AP CLPE+ E + R T L+ ++VP +D C+
Sbjct: 103 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL---- 158
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGI 183
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+ GI
Sbjct: 159 -SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGI 217
Query: 184 YHRVAYTVDWISYIMNT 200
Y +V + WI M T
Sbjct: 218 YTKVTAFLKWIDRSMKT 234
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 99.8 bits (247), Expect = 9e-22, Method: Compositional matrix adjust.
Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVSAG C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 99.8 bits (247), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVSAG C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 99.4 bits (246), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 57/166 (34%), Positives = 84/166 (50%), Gaps = 15/166 (9%)
Query: 36 INVHPYFKFTPQADRY--DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXX 93
I + P+ + ++Y D+A+L LD P+ ++ PIC+ +K
Sbjct: 71 IRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADK---EYTNIFLKFGSGYV 127
Query: 94 XXXSRLRPK-----TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQ 148
R+ K LQ + VP++D C R K IY+ M CAG+ G +DSCQ
Sbjct: 128 SGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTK-----FTIYNNMFCAGFHEGGRDSCQ 182
Query: 149 GDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GD+GGP + E G FL GI+S G CA +G+ GIY +V+ V+WI
Sbjct: 183 GDAGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 99.4 bits (246), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 61/189 (32%), Positives = 91/189 (48%), Gaps = 9/189 (4%)
Query: 11 QVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 70
+V LG + ++S E T + I HP + + + D+A+L+L RP+ + +I P
Sbjct: 53 EVKLGAHQLDSYSEDAKVSTL--KDIIPHP--SYLQEGSQGDIALLQLSRPITFSRYIRP 108
Query: 71 ICLPEKGEDXXXXXXXXXXX--XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
I LP S L PK LQ ++VP+I C + +
Sbjct: 109 ISLPAANASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPE 168
Query: 129 ---VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYH 185
+ ++M+CAGY G KD+CQGDSGGPL G W+L GIVS G +C + +PG+Y
Sbjct: 169 EPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYT 228
Query: 186 RVAYTVDWI 194
+ WI
Sbjct: 229 LASSYASWI 237
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 99.4 bits (246), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPK-----TLQAVDVPIIDNRQCERWH 121
++AP CLPE+ D R K L+ ++VP +D C+
Sbjct: 103 NVAPACLPER--DWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKL-- 158
Query: 122 KSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQP 181
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+
Sbjct: 159 ---SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKY 215
Query: 182 GIYHRVAYTVDWISYIMNT 200
GIY +V + WI M T
Sbjct: 216 GIYTKVTAFLKWIDRSMKT 234
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 99.0 bits (245), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKS 123
++AP CLPE+ E + R T L+ ++VP +D C+
Sbjct: 103 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL---- 158
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGI 183
+ +I M CAGY +D+CQGD+GGP + +F+ GIVS G CA++G+ GI
Sbjct: 159 -SSSFIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGI 217
Query: 184 YHRVAYTVDWISYIMNT 200
Y +V + WI M T
Sbjct: 218 YTKVTAFLKWIDRSMKT 234
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 99.0 bits (245), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 55/162 (33%), Positives = 82/162 (50%), Gaps = 12/162 (7%)
Query: 43 KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPK 102
+F + +D+AVLRL P+++ ++AP CLPEK D R K
Sbjct: 79 RFVKETYDFDIAVLRLKTPIRFRRNVAPACLPEK--DWAEATLMTQKTGIVSGFGRTHEK 136
Query: 103 -----TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMM 157
TL+ ++VP +D C+ + I M CAGY +D+CQGDSGGP +
Sbjct: 137 GRLSSTLKMLEVPYVDRSTCKL-----SSSFTITPNMFCAGYDTQPEDACQGDSGGPHVT 191
Query: 158 ERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
+F+ GIVS G CA++G+ G+Y +V+ + WI IM
Sbjct: 192 RFKDTYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWIDKIMK 233
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 99.0 bits (245), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPK-----TLQAVDVPIIDNRQCERWH 121
++AP CLPE+ D R K L+ ++VP +D C+
Sbjct: 103 NVAPACLPER--DWAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKL-- 158
Query: 122 KSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQP 181
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+
Sbjct: 159 ---SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKY 215
Query: 182 GIYHRVAYTVDWISYIMNT 200
GIY +V + WI M T
Sbjct: 216 GIYTKVTAFLKWIDRSMKT 234
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 99.0 bits (245), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 61/189 (32%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 11 QVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 70
+V LG + ++S E T + I HP + + + D+A+L+L RP+ + +I P
Sbjct: 53 EVKLGAHQLDSYSEDAKVSTL--KDIIPHP--SYLQEGSQGDIALLQLSRPITFSRYIRP 108
Query: 71 ICLP--EKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
I LP + S L PK LQ ++VP+I C + +
Sbjct: 109 ISLPAAQASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPE 168
Query: 129 ---VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYH 185
+ ++M+CAGY G KD+CQGDSGGPL G W+L GIVS G +C + +PG+Y
Sbjct: 169 EPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYT 228
Query: 186 RVAYTVDWI 194
+ WI
Sbjct: 229 LASSYASWI 237
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 99.0 bits (245), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 61/189 (32%), Positives = 92/189 (48%), Gaps = 9/189 (4%)
Query: 11 QVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 70
+V LG + ++S E T + I HP + + + D+A+L+L RP+ + +I P
Sbjct: 53 EVKLGAHQLDSYSEDAKVSTL--KDIIPHP--SYLQEGSQGDIALLQLSRPITFSRYIRP 108
Query: 71 ICLP--EKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
I LP + S L PK LQ ++VP+I C + +
Sbjct: 109 ISLPAAQASFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPE 168
Query: 129 ---VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYH 185
+ ++M+CAGY G KD+CQGDSGGPL G W+L GIVS G +C + +PG+Y
Sbjct: 169 EPHFVQEDMVCAGYVEGGKDACQGDSGGPLSCPVEGLWYLTGIVSWGDACGARNRPGVYT 228
Query: 186 RVAYTVDWI 194
+ WI
Sbjct: 229 LASSYASWI 237
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 99.0 bits (245), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 56/179 (31%), Positives = 89/179 (49%), Gaps = 20/179 (11%)
Query: 35 KINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXXXX 85
KI +HP + + DR D+A+L+L RP++ +I P+CLP+K G
Sbjct: 132 KIYIHPRYNWKENLDR-DIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGW 190
Query: 86 XXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GG 142
+ ++P LQ V++P+++ C+ + I D M CAGY+ G
Sbjct: 191 GNRRETWTTSVAEVQPSVLQVVNLPLVERPVCK-----ASTRIRITDNMFCAGYKPGEGK 245
Query: 143 AKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 246 RGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 304
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 99.0 bits (245), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 56/179 (31%), Positives = 89/179 (49%), Gaps = 20/179 (11%)
Query: 35 KINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXXXX 85
KI +HP + + DR D+A+L+L RP++ +I P+CLP+K G
Sbjct: 83 KIYIHPRYNWKENLDR-DIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGW 141
Query: 86 XXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GG 142
+ ++P LQ V++P+++ C+ + I D M CAGY+ G
Sbjct: 142 GNRRETWTTSVAEVQPSVLQVVNLPLVERPVCK-----ASTRIRITDNMFCAGYKPGEGK 196
Query: 143 AKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 197 RGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 99.0 bits (245), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ ++P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 98.6 bits (244), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 56/179 (31%), Positives = 89/179 (49%), Gaps = 20/179 (11%)
Query: 35 KINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXXXX 85
KI +HP + + DR D+A+L+L RP++ +I P+CLP+K G
Sbjct: 83 KIYIHPRYNWKENLDR-DIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGW 141
Query: 86 XXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GG 142
+ ++P LQ V++P+++ C+ + I D M CAGY+ G
Sbjct: 142 GNRRETWTTSVAEVQPSVLQVVNLPLVERPVCK-----ASTRIRITDNMFCAGYKPGEGK 196
Query: 143 AKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 197 RGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 255
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 98.6 bits (244), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTTNVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+CQGDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 98.6 bits (244), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 62/196 (31%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
A++ +V +GD N+ E V + H +FT + +D+AVLRL P+ +
Sbjct: 47 AKRFKVRVGDR--NTEQEEGGEAVHEVEVVIKHN--RFTKETYDFDIAVLRLKTPITFRM 102
Query: 67 HIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKT-LQAVDVPIIDNRQCERWHKS 123
++AP CLPE+ E + R T L+ ++VP +D C+
Sbjct: 103 NVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKL---- 158
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGI 183
+ +I M CAGY +D+CQGDSGGP + +F+ GIVS G CA++G+ GI
Sbjct: 159 -SSSFIITQNMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGI 217
Query: 184 YHRVAYTVDWISYIMN 199
Y +V + WI M
Sbjct: 218 YTKVTAFLKWIDRSMK 233
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 98.6 bits (244), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 55/174 (31%), Positives = 88/174 (50%), Gaps = 13/174 (7%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP--EKGEDXXXXXXXXXXX 90
+ KI +HP + + DR D+A+++L +PV + +I P+CLP E
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 91 XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GGAKDSC 147
+ +P LQ V++PI++ C+ + + I D M CAGY+ G D+C
Sbjct: 140 GWGNLKEKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDEGKRGDAC 194
Query: 148 QGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 195 EGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 248
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 98.2 bits (243), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 57/181 (31%), Positives = 91/181 (50%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI VHP + + DR D+A+L+L +PV + +I P+CLP+K G
Sbjct: 81 LEKIYVHPRYNWRENLDR-DIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ ++P LQ V++PI++ C+ + I D M CAG++
Sbjct: 140 GWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCK-----ASTRIRITDNMFCAGFKVND 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
D+C+GDSGGP +M+ RW+ +GIVSAG C ++G+ G Y V WI ++
Sbjct: 195 TKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRKGKYGFYTHVFRLKRWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 98.2 bits (243), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 66/170 (38%), Positives = 92/170 (54%), Gaps = 10/170 (5%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXX-XXXXXX 91
V +I VHP F +T Q D+A+L L+ PV+ H+ + LP E
Sbjct: 74 VSRIIVHPQF-YTAQIGA-DIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWG 131
Query: 92 XXXXXSRLRPK-TLQAVDVPIIDNRQCE-RWHKS--NGINV-VIYDEMMCAGYRGGAKDS 146
RL P L+ V VPI++N C+ ++H G +V ++ D+M+CAG +DS
Sbjct: 132 DVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDS 189
Query: 147 CQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISY 196
CQGDSGGPL+ + G W G+VS G CAQ +PGIY RV Y +DWI +
Sbjct: 190 CQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 98.2 bits (243), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 59/164 (35%), Positives = 82/164 (50%), Gaps = 10/164 (6%)
Query: 33 VRKINVHPYFK-FTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXX 91
+++I HP+F FT YD+A+L L++P +Y + PICLP+
Sbjct: 80 LKRIISHPFFNDFTFD---YDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGW 136
Query: 92 XXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDS 151
LQ ++ +I+ CE N + I MMC G+ G DSCQGDS
Sbjct: 137 GHTQYGGTGALILQKGEIRVINQTTCE-----NLLPQQITPRMMCVGFLSGGVDSCQGDS 191
Query: 152 GGPLM-MERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GGPL +E GR F G+VS G CAQ+ +PG+Y R+ DWI
Sbjct: 192 GGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWI 235
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 98.2 bits (243), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 66/170 (38%), Positives = 92/170 (54%), Gaps = 10/170 (5%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXX-XXXXXX 91
V +I VHP F +T Q D+A+L L+ PV+ H+ + LP E
Sbjct: 74 VSRIIVHPQF-YTAQIGA-DIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWG 131
Query: 92 XXXXXSRLRPK-TLQAVDVPIIDNRQCE-RWHKS--NGINV-VIYDEMMCAGYRGGAKDS 146
RL P L+ V VPI++N C+ ++H G +V ++ D+M+CAG +DS
Sbjct: 132 DVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDS 189
Query: 147 CQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISY 196
CQGDSGGPL+ + G W G+VS G CAQ +PGIY RV Y +DWI +
Sbjct: 190 CQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 97.8 bits (242), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 66/170 (38%), Positives = 92/170 (54%), Gaps = 10/170 (5%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXX-XXXXXX 91
V +I VHP F +T Q D+A+L L+ PV+ H+ + LP E
Sbjct: 74 VSRIIVHPQF-YTAQIGA-DIALLELEEPVKVSSHVHTVTLPPASETFPPGMPCWVTGWG 131
Query: 92 XXXXXSRLRPK-TLQAVDVPIIDNRQCE-RWHKS--NGINV-VIYDEMMCAGYRGGAKDS 146
RL P L+ V VPI++N C+ ++H G +V ++ D+M+CAG +DS
Sbjct: 132 DVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAG--NTRRDS 189
Query: 147 CQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISY 196
CQGDSGGPL+ + G W G+VS G CAQ +PGIY RV Y +DWI +
Sbjct: 190 CQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 97.8 bits (242), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKIGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 97.8 bits (242), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 58/166 (34%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 36 INVHPYFKFTPQADRY--DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXX 93
I + P+ F + Y D+A+L LD P+ ++ PIC+ +K
Sbjct: 71 IRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADK---EYTNIFLKFGSGYV 127
Query: 94 XXXSRLRPK-----TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQ 148
R+ K LQ + VP++D C R K I + M CAG+ G +DSCQ
Sbjct: 128 SGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTK-----FTITNNMFCAGFHEGGRDSCQ 182
Query: 149 GDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GDSGGP + E G FL GI+S G CA +G+ GIY +V+ V+WI
Sbjct: 183 GDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 97.8 bits (242), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 58/166 (34%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 36 INVHPYFKFTPQADRY--DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXX 93
I + P+ F + Y D+A+L LD P+ ++ PIC+ +K
Sbjct: 71 IRIIPHHNFNAAINTYNHDIALLELDEPLVLNSYVTPICIADK---EYTNIFLKFGSGYV 127
Query: 94 XXXSRLRPK-----TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQ 148
R+ K LQ + VP++D C R K I + M CAG+ G +DSCQ
Sbjct: 128 SGWGRVFHKGRAALVLQYLRVPLVDRATCLRSTK-----FTITNNMFCAGFHEGGRDSCQ 182
Query: 149 GDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GDSGGP + E G FL GI+S G CA +G+ GIY +V+ V+WI
Sbjct: 183 GDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 97.4 bits (241), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGKGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 97.4 bits (241), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 97.4 bits (241), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKFGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 97.4 bits (241), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 97.4 bits (241), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 97.4 bits (241), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 117 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 175
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 176 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 230
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 231 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 290
Query: 199 N 199
+
Sbjct: 291 D 291
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 97.4 bits (241), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 97.4 bits (241), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 97.4 bits (241), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 97.4 bits (241), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 113 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 171
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 172 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 226
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 227 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 286
Query: 199 N 199
+
Sbjct: 287 D 287
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 97.4 bits (241), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 246 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 304
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 305 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 359
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 360 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 419
Query: 199 N 199
+
Sbjct: 420 D 420
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 97.4 bits (241), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 111 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 169
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 170 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 224
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 225 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 284
Query: 199 N 199
+
Sbjct: 285 D 285
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 97.4 bits (241), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 111 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 169
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 170 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 224
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 225 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 284
Query: 199 N 199
+
Sbjct: 285 D 285
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 97.4 bits (241), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 113 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 171
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 172 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 226
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 227 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 286
Query: 199 N 199
+
Sbjct: 287 D 287
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 97.4 bits (241), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 59/164 (35%), Positives = 81/164 (49%), Gaps = 10/164 (6%)
Query: 33 VRKINVHPYFK-FTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXX 91
+++I HP+F FT YD+A+L L++P +Y + PICLP+
Sbjct: 80 LKRIISHPFFNDFTFD---YDIALLELEKPAEYSSMVRPICLPDASHVFPAGKAIWVTGW 136
Query: 92 XXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDS 151
LQ ++ +I CE N + I MMC G+ G DSCQGDS
Sbjct: 137 GHTQYGGTGALILQKGEIRVIQQTTCE-----NLLPQQITPRMMCVGFLSGGVDSCQGDS 191
Query: 152 GGPLM-MERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GGPL +E GR F G+VS G CAQ+ +PG+Y R+ DWI
Sbjct: 192 GGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWI 235
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 97.4 bits (241), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 117 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 175
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 176 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 230
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 231 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 290
Query: 199 N 199
+
Sbjct: 291 D 291
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 97.4 bits (241), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 110 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 168
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 169 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 223
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 224 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 283
Query: 199 N 199
+
Sbjct: 284 D 284
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 97.4 bits (241), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 111 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 169
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 170 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 224
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 225 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 284
Query: 199 N 199
+
Sbjct: 285 D 285
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 97.1 bits (240), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 111 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 169
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 170 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 224
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 225 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 284
Query: 199 N 199
+
Sbjct: 285 D 285
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 97.1 bits (240), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCRDDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 97.1 bits (240), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 13/174 (7%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP--EKGEDXXXXXXXXXXX 90
+ KI +HP + + DR D+A+++L +PV + +I P+CLP E
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 91 XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GGAKDSC 147
+P LQ V++PI++ C+ + + I D M CAGY+ G D+C
Sbjct: 140 GWGNLKETGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDEGKRGDAC 194
Query: 148 QGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 195 EGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 248
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 97.1 bits (240), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGPLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 97.1 bits (240), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 13/174 (7%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP--EKGEDXXXXXXXXXXX 90
+ KI +HP + + DR D+A+++L +PV + +I P+CLP E
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 91 XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GGAKDSC 147
+P LQ V++PI++ C+ + + I D M CAGY+ G D+C
Sbjct: 140 GWGNLKETGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDEGKRGDAC 194
Query: 148 QGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 195 EGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 248
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 96.7 bits (239), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 130 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 188
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 189 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 243
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GD+GGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 244 GKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 303
Query: 199 N 199
+
Sbjct: 304 D 304
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 96.3 bits (238), Expect = 9e-21, Method: Compositional matrix adjust.
Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GD+GGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 96.3 bits (238), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI VHP + + DR D+A+L+L +PV + +I P+CLP+K G
Sbjct: 81 LEKIYVHPRYNWRENLDR-DIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ ++P LQ V++PI++ C+ + I D M CAG++
Sbjct: 140 GWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCK-----ASTRIRITDNMFCAGFKVND 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
D+C+GDSGGP +M+ RW+ +GIVS G C ++G+ G Y V WI ++
Sbjct: 195 TKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKAWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 96.3 bits (238), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 18/177 (10%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ +
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDR--ETAASLLQAGYKGR 137
Query: 93 XXXXSRLR-----PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GGAK 144
L+ P LQ V++PI++ C+ + + I D M CAGY+ G
Sbjct: 138 VTGWGNLKETWGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDEGKRG 192
Query: 145 DSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 193 DACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 249
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 96.3 bits (238), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 82 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 140
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 141 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 195
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GD+GGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 196 GKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 255
Query: 199 N 199
+
Sbjct: 256 D 256
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 96.3 bits (238), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 112 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 170
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 171 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 225
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GD+GGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 226 GKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 285
Query: 199 N 199
+
Sbjct: 286 D 286
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 95.9 bits (237), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 57/166 (34%), Positives = 82/166 (49%), Gaps = 15/166 (9%)
Query: 36 INVHPYFKFTPQADRY--DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXX 93
I + P+ + + Y D+A+L LD P+ ++ PIC+ +K
Sbjct: 71 IRIIPHHNYNAAINTYNHDIALLELDEPLVLNSYVTPICIADK---EYTNIFLKFGSGYV 127
Query: 94 XXXSRLRPK-----TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQ 148
R+ K LQ + VP++D C R K I + M CAG+ G +DSCQ
Sbjct: 128 SGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTK-----FTITNNMFCAGFHEGGRDSCQ 182
Query: 149 GDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GDSGGP + E G FL GI+S G CA +G+ GIY +V+ V+WI
Sbjct: 183 GDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWI 228
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 95.9 bits (237), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 54/181 (29%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR ++A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-NIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 95.5 bits (236), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+ DSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEADSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 95.5 bits (236), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 55/166 (33%), Positives = 85/166 (51%), Gaps = 5/166 (3%)
Query: 31 FGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXX 90
G+ + HP + + +D+A++RL+R V++ +I P+CLP+ E+
Sbjct: 112 LGIEETIQHPDYVDGSKDRYHDIALIRLNRQVEFTNYIRPVCLPQPNEEVQVGQRLTVVG 171
Query: 91 XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGD 150
+ Q + VP++ QC + + G+ V +CAG AKDSC GD
Sbjct: 172 WGRTETGQYS-TIKQKLAVPVVHAEQCAKTFGAAGVRV--RSSQLCAGGEK-AKDSCGGD 227
Query: 151 SGGPLMMERTGR-WFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWIS 195
SGGPL+ ER + +FL G+VS G +C +G PGIY +V DWI
Sbjct: 228 SGGPLLAERANQQFFLEGLVSFGATCGTEGWPGIYTKVGKYRDWIE 273
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 95.1 bits (235), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI VHP + + DR D+A+L+L +PV + +I P+CLP+K G
Sbjct: 81 LEKIYVHPRYNWRENLDR-DIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ ++P LQ V++PI++ C+ + I D M CAG++
Sbjct: 140 GWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCK-----ASTRIRITDNMFCAGFKVND 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
D+C+GD+GGP +M+ RW+ +GIVS G C ++G+ G Y V WI ++
Sbjct: 195 TKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKRWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 94.4 bits (233), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 53/181 (29%), Positives = 90/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAG++
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGFKVND 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
D+C+GDSGGP +M+ RW+ +GIVS G C ++G+ G Y V WI ++
Sbjct: 195 TKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 94.4 bits (233), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 58/164 (35%), Positives = 81/164 (49%), Gaps = 10/164 (6%)
Query: 33 VRKINVHPYFK-FTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXX 91
+++I HP+F FT YD+A+L L++P +Y + PI LP+
Sbjct: 80 LKRIISHPFFNDFTFD---YDIALLELEKPAEYSSMVRPISLPDASHVFPAGKAIWVTGW 136
Query: 92 XXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDS 151
LQ ++ +I+ CE N + I MMC G+ G DSCQGDS
Sbjct: 137 GHTQYGGTGALILQKGEIRVINQTTCE-----NLLPQQITPRMMCVGFLSGGVDSCQGDS 191
Query: 152 GGPLM-MERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GGPL +E GR F G+VS G CAQ+ +PG+Y R+ DWI
Sbjct: 192 GGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWI 235
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 94.4 bits (233), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+ DSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 195 GKRGDACEPDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 94.0 bits (232), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 85 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 143
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CA Y+
Sbjct: 144 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAYYKPDE 198
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+C+GDSGGP +M+ RW+ +GIVS G C + G+ G Y V WI ++
Sbjct: 199 GKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVI 258
Query: 199 N 199
+
Sbjct: 259 D 259
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 93.6 bits (231), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 62/170 (36%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
V +I VHP F D+A+L L+ PV + + LP E
Sbjct: 74 VSRIIVHPQFYIIQTGA--DIALLELEEPVNISSRVHTVMLPPASETFPPGMPCWVTGWG 131
Query: 93 XXXXSRLRPKT--LQAVDVPIIDNRQCE-RWHKS--NGINV-VIYDEMMCAGYRGGAKDS 146
P L+ V VPI++N C+ ++H G +V +I D+M+CAG +DS
Sbjct: 132 DVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDS 189
Query: 147 CQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISY 196
CQGDSGGPL+ + G W G+VS G CAQ +PGIY RV Y +DWI +
Sbjct: 190 CQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 92.4 bits (228), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 33 VRKINVHPYFK---FTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXX 89
++K+ + FK + D+ +L+L + ++ +CLP +D
Sbjct: 65 IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTT 124
Query: 90 XXXXXXXSRLR-PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQ 148
+ P LQ +P++ N C+++ + I D M+CAG G SC
Sbjct: 125 GWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTK-----IKDAMICAGASG--VSSCM 177
Query: 149 GDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
GDSGGPL+ ++ G W L+GIVS G S PG+Y RV V+W+ +
Sbjct: 178 GDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL 227
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 11/170 (6%)
Query: 33 VRKINVHPYFK---FTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXX 89
++K+ + FK + D+ +L+L + ++ +CLP +D
Sbjct: 80 IQKLKIAKVFKNSKYNSLTINNDITLLKLSTAASFSQTVSAVCLPSASDDFAAGTTCVTT 139
Query: 90 XXXXXXXSRLR-PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQ 148
+ P LQ +P++ N C+++ + I D M+CAG G SC
Sbjct: 140 GWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWGTK-----IKDAMICAGASG--VSSCM 192
Query: 149 GDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
GDSGGPL+ ++ G W L+GIVS G S PG+Y RV V+W+ +
Sbjct: 193 GDSGGPLVCKKNGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQQTL 242
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 92.0 bits (227), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 61/170 (35%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
V +I VHP F D+A+L L+ PV + + LP E
Sbjct: 74 VSRIIVHPQFYIIQTGA--DIALLELEEPVNISSRVHTVMLPPASETFPPGMPCWVTGWG 131
Query: 93 XXXXSRLRPKT--LQAVDVPIIDNRQCE-RWHKS--NGINV-VIYDEMMCAGYRGGAKDS 146
P L+ V VPI++N C+ ++H G +V +I D+M+CAG +DS
Sbjct: 132 DVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDS 189
Query: 147 CQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISY 196
C+GDSGGPL+ + G W G+VS G CAQ +PGIY RV Y +DWI +
Sbjct: 190 CKGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 92.0 bits (227), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 6 SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM 65
++++ V LG+Y + + ++++ VHP ++ D+A+L L +P
Sbjct: 46 ESKKLLVRLGEYDLRRWEKW--ELDLDIKEVFVHP--NYSKSTTDNDIALLHLAQPATLS 101
Query: 66 PHIAPICLPEKGEDXXXXXXXXXXXXXX---------XXXSRLRPKTLQAVDVPIIDNRQ 116
I PICLP+ G R R L + +P++ + +
Sbjct: 102 QTIVPICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNE 161
Query: 117 CERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCA 176
C S ++ ++ + M+CAG G +D+C+GDSGGP++ G WFL+G+VS G C
Sbjct: 162 C-----SEVMSNMVSENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCG 216
Query: 177 QQGQPGIYHRVAYTVDWI 194
G+Y +V+ +DWI
Sbjct: 217 LLHNYGVYTKVSRYLDWI 234
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 91.7 bits (226), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 6 SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM 65
++++ V LG+Y + + ++++ VHP ++ D+A+L L +P
Sbjct: 46 ESKKLLVRLGEYDLRRWEKW--ELDLDIKEVFVHP--NYSKSTTDNDIALLHLAQPATLS 101
Query: 66 PHIAPICLPEKGEDXXXXXXXXXX---------XXXXXXXSRLRPKTLQAVDVPIIDNRQ 116
I PICLP+ G R R L + +P++ + +
Sbjct: 102 QTIVPICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNE 161
Query: 117 CERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCA 176
C S ++ ++ + M+CAG G +D+C+GDSGGP++ G WFL+G+VS G C
Sbjct: 162 C-----SEVMSNMVSENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCG 216
Query: 177 QQGQPGIYHRVAYTVDWI 194
G+Y +V+ +DWI
Sbjct: 217 LLHNYGVYTKVSRYLDWI 234
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 91.7 bits (226), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 83/181 (45%), Gaps = 17/181 (9%)
Query: 31 FGVRKINVH----PYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXX 86
GV+ + H P+ + + D+A++ L P+ +I P+CLP G+
Sbjct: 70 LGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKIC 129
Query: 87 XXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV---IYDEMMCAGYRGGA 143
+ LQ VPII N C NG + I +M CAGY G
Sbjct: 130 TVTGWGNTQYYGQQAGVLQEARVPIISNDVC------NGADFYGNQIKPKMFCAGYPEGG 183
Query: 144 KDSCQGDSGGPLMME----RTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
D+CQGDSGGP + E RT RW L GIVS G CA +PG+Y +V+ +WI +
Sbjct: 184 IDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIK 243
Query: 200 T 200
T
Sbjct: 244 T 244
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 91.3 bits (225), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 60/181 (33%), Positives = 83/181 (45%), Gaps = 17/181 (9%)
Query: 31 FGVRKINVH----PYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXX 86
GV+ + H P+ + + D+A++ L P+ +I P+CLP G+
Sbjct: 187 LGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKIC 246
Query: 87 XXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV---IYDEMMCAGYRGGA 143
+ LQ VPII N C NG + I +M CAGY G
Sbjct: 247 TVTGWGNTQYYGQQAGVLQEARVPIISNDVC------NGADFYGNQIKPKMFCAGYPEGG 300
Query: 144 KDSCQGDSGGPLMME----RTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
D+CQGDSGGP + E RT RW L GIVS G CA +PG+Y +V+ +WI +
Sbjct: 301 IDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIK 360
Query: 200 T 200
T
Sbjct: 361 T 361
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 91.3 bits (225), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 60/184 (32%), Positives = 84/184 (45%), Gaps = 17/184 (9%)
Query: 31 FGVRKINVH----PYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXX 86
GV+ + H P+ + + D+A++ L P+ +I P+CLP G+
Sbjct: 187 LGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAGQALVDGKIC 246
Query: 87 XXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV---IYDEMMCAGYRGGA 143
+ LQ VPII N C NG + I +M CAGY G
Sbjct: 247 TVTGWGNTQYYGQQAGVLQEARVPIISNDVC------NGADFYGNQIKPKMFCAGYPEGG 300
Query: 144 KDSCQGDSGGPLMME----RTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
D+CQGDSGGP + E RT RW L GIVS G CA +PG+Y +V+ +WI +
Sbjct: 301 IDACQGDSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWIFQAIK 360
Query: 200 TATN 203
T +
Sbjct: 361 THSE 364
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 90.9 bits (224), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 14/192 (7%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 68
++QV LG++ N AV K+ +HP + + D+ +++L +P ++
Sbjct: 45 RIQVRLGEH--NIAVNEGTEQFIDSVKVIMHP--SYNSRNLDNDIMLIKLSKPASLNSYV 100
Query: 69 APICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
+ + LP S P TL+ +D+PI+ + C +
Sbjct: 101 STVALPSSCASSGTRCLVSGWGNLSGSSSNY-PDTLRCLDLPILSSSSCNSAYPGQ---- 155
Query: 129 VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVA 188
I M CAG+ G KDSCQGDSGGP++ L G+VS GY CAQ+ +PG+Y +V
Sbjct: 156 -ITSNMFCAGFMEGGKDSCQGDSGGPVVCNGQ----LQGVVSWGYGCAQRNKPGVYTKVC 210
Query: 189 YTVDWISYIMNT 200
WIS M++
Sbjct: 211 NYRSWISSTMSS 222
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 90.9 bits (224), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK---------GEDXXXX 83
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++ G
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVT 139
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR--- 140
+ +P LQ V++PI++ C+ + + I D M CAGY+
Sbjct: 140 GWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDE 194
Query: 141 GGAKDSCQGDSGGPLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
G D+ +GDSGGP +M+ RW+ +GIVS G + G+ G Y V WI ++
Sbjct: 195 GKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGADRDGKYGFYTHVFRLKKWIQKVI 254
Query: 199 N 199
+
Sbjct: 255 D 255
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 90.9 bits (224), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 56/165 (33%), Positives = 79/165 (47%), Gaps = 6/165 (3%)
Query: 32 GVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXX 91
G+R+I VH +K P D YD+++ L PV Y + +CLP+ +
Sbjct: 68 GLRRIIVHEKYKH-PSHD-YDISLAELSSPVPYTNAVHRVCLPDASYEFQPGDVMFVTGF 125
Query: 92 XXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDS 151
L+ V +ID C ++ N I M+CAG G D+CQGDS
Sbjct: 126 GALKNDGYSQNHLRQAQVTLIDATTC---NEPQAYNDAITPRMLCAGSLEGKTDACQGDS 182
Query: 152 GGPLMM-ERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWIS 195
GGPL+ + W+L GIVS G CA+ +PG+Y RV DWI+
Sbjct: 183 GGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWIT 227
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 90.9 bits (224), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 85/169 (50%), Gaps = 9/169 (5%)
Query: 31 FGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXX 90
GV+ +HP ++ P DVA++ L + PICLPE +
Sbjct: 240 LGVKHTTLHP--QYDPNTFENDVALVELLESPVLNAFVMPICLPEGPQQEGAMVIVSGWG 297
Query: 91 XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGD 150
+ P+TL +++PI+D+ C++ + + + +M+CAG + G KD+C GD
Sbjct: 298 KQFL---QRFPETLMEIEIPIVDHSTCQKAYAP--LKKKVTRDMICAGEKEGGKDACAGD 352
Query: 151 SGGPL--MMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYI 197
SGGP+ + G+W+L+G VS G C ++ + G+Y + + DWI +
Sbjct: 353 SGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQRV 401
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 90.5 bits (223), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 85/169 (50%), Gaps = 9/169 (5%)
Query: 31 FGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXX 90
GV+ +HP ++ P DVA++ L + PICLPE +
Sbjct: 85 LGVKHTTLHP--QYDPNTFENDVALVELLESPVLNAFVMPICLPEGPQQEGAMVIVSGWG 142
Query: 91 XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGD 150
+ P+TL +++PI+D+ C++ + + + +M+CAG + G KD+C GD
Sbjct: 143 KQFL---QRFPETLMEIEIPIVDHSTCQKAYAP--LKKKVTRDMICAGEKEGGKDACAGD 197
Query: 151 SGGPL--MMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYI 197
SGGP+ + G+W+L+G VS G C ++ + G+Y + + DWI +
Sbjct: 198 SGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQRV 246
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 90.1 bits (222), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 61/187 (32%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+ H
Sbjct: 66 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAH 121
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 122 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 177
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 178 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 231
Query: 188 AYTVDWI 194
VDWI
Sbjct: 232 CNYVDWI 238
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 89.7 bits (221), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 60/170 (35%), Positives = 84/170 (49%), Gaps = 10/170 (5%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
V +I VHP F D+A+L L+ PV + + LP E
Sbjct: 74 VSRIIVHPQFYIIQTG--ADIALLELEEPVNISSRVHTVMLPPASETFPPGMPCWVTGWG 131
Query: 93 XXXXSRLRPKT--LQAVDVPIIDNRQCE-RWHKS--NGINV-VIYDEMMCAGYRGGAKDS 146
P L+ V VPI++N C+ ++H G +V +I D+M+CAG +DS
Sbjct: 132 DVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAG--NSQRDS 189
Query: 147 CQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISY 196
C+GDSGGPL+ + G W G+VS CAQ +PGIY RV Y +DWI +
Sbjct: 190 CKGDSGGPLVCKVNGTWLQAGVVSWDEGCAQPNRPGIYTRVTYYLDWIHH 239
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 89.4 bits (220), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 53/153 (34%), Positives = 79/153 (51%), Gaps = 5/153 (3%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVP 110
D+A+++L+ V +I PICLP K + R + L VD+P
Sbjct: 88 DIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWGLTQRGFLARNLMYVDIP 147
Query: 111 IIDNRQC-ERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMM--ERTGRWFLIG 167
I+D+++C + K + M+CAG G KDSC+GDSGG L+ T RWF+ G
Sbjct: 148 IVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGG 207
Query: 168 IVSAG-YSCAQQGQPGIYHRVAYTVDWISYIMN 199
IVS G +C + GQ G+Y +V + WI I++
Sbjct: 208 IVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS 240
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 89.0 bits (219), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 53/153 (34%), Positives = 79/153 (51%), Gaps = 5/153 (3%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVP 110
D+A+++L+ V +I PICLP K + R + L VD+P
Sbjct: 174 DIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWGLTQRGFLARNLMYVDIP 233
Query: 111 IIDNRQC-ERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMM--ERTGRWFLIG 167
I+D+++C + K + M+CAG G KDSC+GDSGG L+ T RWF+ G
Sbjct: 234 IVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGG 293
Query: 168 IVSAG-YSCAQQGQPGIYHRVAYTVDWISYIMN 199
IVS G +C + GQ G+Y +V + WI I++
Sbjct: 294 IVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS 326
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 88.6 bits (218), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 53/153 (34%), Positives = 79/153 (51%), Gaps = 5/153 (3%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVP 110
D+A+++L+ V +I PICLP K + R + L VD+P
Sbjct: 249 DIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWGLTQRGFLARNLMYVDIP 308
Query: 111 IIDNRQC-ERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMM--ERTGRWFLIG 167
I+D+++C + K + M+CAG G KDSC+GDSGG L+ T RWF+ G
Sbjct: 309 IVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGG 368
Query: 168 IVSAG-YSCAQQGQPGIYHRVAYTVDWISYIMN 199
IVS G +C + GQ G+Y +V + WI I++
Sbjct: 369 IVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS 401
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 88.6 bits (218), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 43 KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPK 102
+FT + +D+AVLRL P+ + ++AP LP + P
Sbjct: 79 RFTKETYDFDIAVLRLKTPITFRMNVAPASLPTAPPATGTKCLISGWGNTASSGADY-PD 137
Query: 103 TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGR 162
LQ +D P++ +CE + I M C G+ G KDSCQGDSGGP++
Sbjct: 138 ELQCLDAPVLSQAKCEASYPGK-----ITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQ-- 190
Query: 163 WFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
L G+VS G CAQ+ +PG+Y +V V WI
Sbjct: 191 --LQGVVSWGDGCAQKNKPGVYTKVYNYVKWI 220
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 88.2 bits (217), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 34 RKINVHPYF------KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG---EDXXXXX 84
+++N+ P+ + + R D+A+L+L P + P CLP D
Sbjct: 81 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 140
Query: 85 XXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAK 144
+ L L+ +P+I+N+ C R+ NG + +CAG+ G
Sbjct: 141 ITGWGETQGTFGAGL----LKEAQLPVIENKVCNRYEFLNG---RVQSTELCAGHLAGGT 193
Query: 145 DSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
DSCQGDSGGPL+ ++ L G+ S G CA+ +PG+Y RV+ V WI +M
Sbjct: 194 DSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 247
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 88.2 bits (217), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 34 RKINVHPYF------KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG---EDXXXXX 84
+++N+ P+ + + R D+A+L+L P + P CLP D
Sbjct: 78 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 137
Query: 85 XXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAK 144
+ L L+ +P+I+N+ C R+ NG + +CAG+ G
Sbjct: 138 ITGWGETQGTFGAGL----LKEAQLPVIENKVCNRYEFLNG---RVQSTELCAGHLAGGT 190
Query: 145 DSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
DSCQGDSGGPL+ ++ L G+ S G CA+ +PG+Y RV+ V WI +M
Sbjct: 191 DSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 244
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 88.2 bits (217), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 52/153 (33%), Positives = 79/153 (51%), Gaps = 5/153 (3%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVP 110
D+A+++L+ V +I PICLP K + R + L VD+P
Sbjct: 88 DIALIKLNNKVVINSNITPICLPRKEAESFMRTDDIGTASGWGLTQRGFLARNLMYVDIP 147
Query: 111 IIDNRQC-ERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMM--ERTGRWFLIG 167
I+D+++C + K + M+CAG G KDSC+GD+GG L+ T RWF+ G
Sbjct: 148 IVDHQKCTAAYEKPPYPRGSVTANMLCAGLESGGKDSCRGDAGGALVFLDSETERWFVGG 207
Query: 168 IVSAG-YSCAQQGQPGIYHRVAYTVDWISYIMN 199
IVS G +C + GQ G+Y +V + WI I++
Sbjct: 208 IVSWGSMNCGEAGQYGVYTKVINYIPWIENIIS 240
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 87.4 bits (215), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ I+ +E + KI HP F + D+ +++L P
Sbjct: 44 SRIQVRLGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP S P LQ + P++ N C+ +
Sbjct: 100 VATVSLPRSCAAAGTECLISGWGNTKSSGSSY-PSLLQCLKAPVLSNSSCKSSYPGQ--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I M+C G+ G KDSCQGDSGGP++ L GIVS GY CAQ+ +PG+Y +V
Sbjct: 156 --ITGNMICVGFLQGGKDSCQGDSGGPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKV 209
Query: 188 AYTVDWI 194
V+WI
Sbjct: 210 CNYVNWI 216
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 87.4 bits (215), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 10/171 (5%)
Query: 34 RKINVHPYF------KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXX 87
+++N+ P+ + + R D+A+L+L P + P CLP
Sbjct: 78 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSP-NYVVADRTEC 136
Query: 88 XXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSC 147
L +P+I+N+ C R+ NG + +CAG+ G DSC
Sbjct: 137 FITGWGETQGTFGAGLLMEAQLPVIENKVCNRYEFLNG---RVQSTELCAGHLAGGTDSC 193
Query: 148 QGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
QGDSGGPL+ ++ L G+ S G CA+ +PG+Y RV+ V WI +M
Sbjct: 194 QGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 244
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 87.4 bits (215), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + + I HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFVNAAKIIK-HPNFDH--KTLNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 87.4 bits (215), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRETYNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEA-----SSS 153
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
+I D M+C G+ G KD+CQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 154 FIITDNMVCVGFLEGGKDACQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 87.0 bits (214), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 34 RKINVHPYF------KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG---EDXXXXX 84
+++N+ P+ + + R D+A+L+L P + P CLP D
Sbjct: 81 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 140
Query: 85 XXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAK 144
+ L L+ +P+I+N+ C R+ NG + +CAG+ G
Sbjct: 141 ITGWGETQGTFGAGL----LKEAQLPVIENKVCNRYEFLNG---RVQSTELCAGHLAGGT 193
Query: 145 DSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
DSCQGD+GGPL+ ++ L G+ S G CA+ +PG+Y RV+ V WI +M
Sbjct: 194 DSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 247
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 87.0 bits (214), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 34 RKINVHPYF------KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG---EDXXXXX 84
+++N+ P+ + + R D+A+L+L P + P CLP D
Sbjct: 80 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 139
Query: 85 XXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAK 144
+ L L+ +P+I+N+ C R+ NG + +CAG+ G
Sbjct: 140 ITGWGETQGTFGAGL----LKEAQLPVIENKVCNRYEFLNG---RVQSTELCAGHLAGGT 192
Query: 145 DSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
DSCQGD+GGPL+ ++ L G+ S G CA+ +PG+Y RV+ V WI +M
Sbjct: 193 DSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 246
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 87.0 bits (214), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 63/193 (32%), Positives = 87/193 (45%), Gaps = 13/193 (6%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRK-INVHPYFKFTPQADRYDVAVLRL----DRPVQ 63
V V LG + N + TFG+ K I Y F P +D+ ++RL DR
Sbjct: 50 SVSVVLGQHFFNRTTDV--TQTFGIEKYIPYTLYSVFNPS--DHDLVLIRLKKKGDRCAT 105
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXS-RLRPKTLQAVDVPIIDNRQCERWHK 122
+ PICLPE G + +L+ VP++ + +C
Sbjct: 106 RSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCS---S 162
Query: 123 SNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPG 182
I M+CAGY D+CQGDSGGPL E+ G +L GI+S G C + +PG
Sbjct: 163 PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPG 222
Query: 183 IYHRVAYTVDWIS 195
+Y RVA VDWI+
Sbjct: 223 VYTRVANYVDWIN 235
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 87.0 bits (214), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 63/193 (32%), Positives = 87/193 (45%), Gaps = 13/193 (6%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRK-INVHPYFKFTPQADRYDVAVLRL----DRPVQ 63
V V LG + N + TFG+ K I Y F P +D+ ++RL DR
Sbjct: 50 SVSVVLGQHFFNRTTDV--TQTFGIEKYIPYTLYSVFNPS--DHDLVLIRLKKKGDRCAT 105
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXS-RLRPKTLQAVDVPIIDNRQCERWHK 122
+ PICLPE G + +L+ VP++ + +C
Sbjct: 106 RSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCS---S 162
Query: 123 SNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPG 182
I M+CAGY D+CQGDSGGPL E+ G +L GI+S G C + +PG
Sbjct: 163 PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPG 222
Query: 183 IYHRVAYTVDWIS 195
+Y RVA VDWI+
Sbjct: 223 VYTRVANYVDWIN 235
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 87.0 bits (214), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 61/187 (32%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A I LP P LQ +D P++ CE +
Sbjct: 100 VATIALPSSCAPAGTQCLISGWGHTLSSGVN-HPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 87.0 bits (214), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 34 RKINVHPYF------KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG---EDXXXXX 84
+++N+ P+ + + R D+A+L+L P + P CLP D
Sbjct: 78 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 137
Query: 85 XXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAK 144
+ L L+ +P+I+N+ C R+ NG + +CAG+ G
Sbjct: 138 ITGWGETQGTFGAGL----LKEAQLPVIENKVCNRYEFLNG---RVQSTELCAGHLAGGT 190
Query: 145 DSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
DSCQGD+GGPL+ ++ L G+ S G CA+ +PG+Y RV+ V WI +M
Sbjct: 191 DSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 244
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 87.0 bits (214), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 34 RKINVHPYF------KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG---EDXXXXX 84
+++N+ P+ + + R D+A+L+L P + P CLP D
Sbjct: 79 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 138
Query: 85 XXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAK 144
+ L L+ +P+I+N+ C R+ NG + +CAG+ G
Sbjct: 139 ITGWGETQGTFGAGL----LKEAQLPVIENKVCNRYEFLNG---RVQSTELCAGHLAGGT 191
Query: 145 DSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
DSCQGD+GGPL+ ++ L G+ S G CA+ +PG+Y RV+ V WI +M
Sbjct: 192 DSCQGDAGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 245
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 87.0 bits (214), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 60/187 (32%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 87.0 bits (214), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 34 RKINVHPYF------KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG---EDXXXXX 84
+++N+ P+ + + R D+A+L+L P + P CLP D
Sbjct: 77 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYMVADRTECF 136
Query: 85 XXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAK 144
+ L L+ +P+I+N+ C R+ NG + +CAG+ G
Sbjct: 137 ITGWGETQGTFGAGL----LKEAQLPVIENKVCNRYEFLNG---RVQSTELCAGHLAGGT 189
Query: 145 DSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
DSCQGDSGGPL+ ++ L G+ S G CA+ +PG+Y RV+ V WI ++
Sbjct: 190 DSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVL 243
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 87.0 bits (214), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 63/193 (32%), Positives = 87/193 (45%), Gaps = 13/193 (6%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRK-INVHPYFKFTPQADRYDVAVLRL----DRPVQ 63
V V LG + N + TFG+ K I Y F P +D+ ++RL DR
Sbjct: 85 SVSVVLGQHFFNRTTDV--TQTFGIEKYIPYTLYSVFNPS--DHDLVLIRLKKKGDRCAT 140
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXS-RLRPKTLQAVDVPIIDNRQCERWHK 122
+ PICLPE G + +L+ VP++ + +C
Sbjct: 141 RSQFVQPICLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCS---S 197
Query: 123 SNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPG 182
I M+CAGY D+CQGDSGGPL E+ G +L GI+S G C + +PG
Sbjct: 198 PEVYGADISPNMLCAGYFDCKSDACQGDSGGPLACEKNGVAYLYGIISWGDGCGRLHKPG 257
Query: 183 IYHRVAYTVDWIS 195
+Y RVA VDWI+
Sbjct: 258 VYTRVANYVDWIN 270
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 87.0 bits (214), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 60/187 (32%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRETYNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 86.7 bits (213), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 60/187 (32%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 54 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 109
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 110 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 165
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 166 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 219
Query: 188 AYTVDWI 194
VDWI
Sbjct: 220 CNYVDWI 226
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 86.7 bits (213), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 60/187 (32%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 52 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 107
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 108 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 163
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 164 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 217
Query: 188 AYTVDWI 194
VDWI
Sbjct: 218 CNYVDWI 224
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 86.7 bits (213), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 16/174 (9%)
Query: 34 RKINVHPYF------KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKG---EDXXXXX 84
+++N+ P+ + + R D+A+L+L P + P CLP D
Sbjct: 622 QEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECF 681
Query: 85 XXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAK 144
+ L L+ +P+I+N+ C R+ NG + +CAG+ G
Sbjct: 682 ITGWGETQGTFGAGL----LKEAQLPVIENKVCNRYEFLNG---RVQSTELCAGHLAGGT 734
Query: 145 DSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
DSCQGDSGGPL+ ++ L G+ S G CA+ +PG+Y RV+ V WI +M
Sbjct: 735 DSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVM 788
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 86.3 bits (212), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 60/187 (32%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGHTLSSGVN-HPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 86.3 bits (212), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 9/195 (4%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+++ G++ + E LP +R++ +H F P+ DVA+L LDRP+ +I
Sbjct: 191 IKIRAGEWDTLTEKERLPYQERKIRQVIIHS--NFNPKTVVNDVALLLLDRPLVQADNIG 248
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLR-PKTLQAVDVPIIDNRQCERWHKSN--GI 126
ICLP++ + SR R L+ + +P +D +C+ ++ G+
Sbjct: 249 TICLPQQSQIFDSTECFASGWGKKEFGSRHRYSNILKKIQLPTVDRDKCQADLRNTRLGL 308
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMM---ERTGRWFLIGIVSAGYSCAQQGQPGI 183
V+ +CAG G KD+C GD G PL R+ +GIV+ G C + PG+
Sbjct: 309 KFVLDQTFVCAGGEQG-KDTCTGDGGSPLFCPDPRNPSRYMQMGIVAWGIGCGDENVPGV 367
Query: 184 YHRVAYTVDWISYIM 198
Y VA+ +WI M
Sbjct: 368 YANVAHFRNWIDQEM 382
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 85.9 bits (211), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ I+ +E + KI HP F + D+ +++L P
Sbjct: 44 SRIQVRLGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLXSR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP S P LQ + P++ + C+ +
Sbjct: 100 VATVSLPRSCAAAGTECLISGWGNTKSSGSSY-PSLLQCLKAPVLSDSSCKSSYPGQ--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I M+C G+ G KDSCQGDSGGP++ L GIVS GY CAQ+ +PG+Y +V
Sbjct: 156 --ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKV 209
Query: 188 AYTVDWI 194
V+WI
Sbjct: 210 CNYVNWI 216
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 85.9 bits (211), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGD+GGP++ L GIVS GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDAGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 85.5 bits (210), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ I+ +E + KI HP F + D+ +++L P
Sbjct: 44 SRIQVRLGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP S P LQ + P++ + C+ +
Sbjct: 100 VATVSLPRSCAAAGTECLISGWGNTKSSGSSY-PSLLQCLKAPVLSDSSCKSSYPGQ--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I M+C G+ G KDSCQGDSGGP++ L GIVS GY CAQ+ +PG+Y +V
Sbjct: 156 --ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKV 209
Query: 188 AYTVDWI 194
V+WI
Sbjct: 210 CNYVNWI 216
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 85.5 bits (210), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ I+ +E + KI HP F + D+ +++L P
Sbjct: 44 SRIQVRLGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP S P LQ + P++ + C+ +
Sbjct: 100 VATVSLPRSCAAAGTECLISGWGNTKSSGSSY-PSLLQCLKAPVLSDSSCKSSYPGQ--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I M+C G+ G KDSCQGDSGGP++ L GIVS GY CAQ+ +PG+Y +V
Sbjct: 156 --ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKV 209
Query: 188 AYTVDWI 194
V+WI
Sbjct: 210 CNYVNWI 216
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 85.5 bits (210), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ I+ +E + KI HP F + D+ +++L P
Sbjct: 44 SRIQVRLGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP S P LQ + P++ + C+ +
Sbjct: 100 VATVSLPRSCAAAGTECLISGWGNTKSSGSSY-PSLLQCLKAPVLSDSSCKSAYPGQ--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I M+C G+ G KDSCQGDSGGP++ L GIVS GY CAQ+ +PG+Y +V
Sbjct: 156 --ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKV 209
Query: 188 AYTVDWI 194
V+WI
Sbjct: 210 CNYVNWI 216
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 85.5 bits (210), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 54 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 109
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 110 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 165
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGD+GGP++ L GIVS GY CA PG+Y +V
Sbjct: 166 --ITDNMVCVGFLEGGKDSCQGDAGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 219
Query: 188 AYTVDWI 194
VDWI
Sbjct: 220 CNYVDWI 226
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 85.1 bits (209), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 83/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIV GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVEWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 85.1 bits (209), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + ++ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNNIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 85.1 bits (209), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 58/193 (30%), Positives = 88/193 (45%), Gaps = 15/193 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
+V+V LG++ I E + R I HP ++ D+ +++L +P +
Sbjct: 44 SRVEVRLGEHNI-KVTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTY 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+ P+ LP S LQ +++PI+ C +N
Sbjct: 100 VQPVALPSSCAPAGTMCTVSGWGNTMS--STADKNKLQCLNIPILSYSDC-----NNSYP 152
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
+I + M CAGY G KDSCQGDSGGP++ L G+VS GY CA+ G PG+Y +V
Sbjct: 153 GMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKV 208
Query: 188 AYTVDWISYIMNT 200
DW++ M T
Sbjct: 209 CIFNDWLTSTMAT 221
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 85.1 bits (209), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 83/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGD GGP++ L GIVS GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDCGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 85.1 bits (209), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 83/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIV GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVKWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 85.1 bits (209), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 56/187 (29%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ I+ +E + KI HP F + D+ +++L P
Sbjct: 52 SRIQVRLGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSR 107
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP S P LQ + P++ + C+ +
Sbjct: 108 VATVSLPRSCAAAGTECLISGWGNTKSSGSSY-PSLLQCLKAPVLSDSSCKSSYPGQ--- 163
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I M+C G+ G KDSCQGDSGGP++ L GIVS GY CAQ+ +PG+Y +V
Sbjct: 164 --ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ----LQGIVSWGYGCAQKNKPGVYTKV 217
Query: 188 AYTVDWI 194
V+WI
Sbjct: 218 CNYVNWI 224
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 85.1 bits (209), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 82/187 (43%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN V KI HP F + ++ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN--VLEGDEQFVNAAKIIKHP--NFDRKTLNNNIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 85.1 bits (209), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 52 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 107
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P L+ +D P++ CE +
Sbjct: 108 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLKCLDAPLLPQADCEASYPGK--- 163
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 164 --ITDNMVCVGFLEGGKDSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 217
Query: 188 AYTVDWI 194
VDWI
Sbjct: 218 CNYVDWI 224
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 84.7 bits (208), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 52 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 107
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 108 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 163
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G KDSCQG+SGGP++ L GIVS GY CA PG+Y +V
Sbjct: 164 --ITDNMVCVGFLEGGKDSCQGNSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 217
Query: 188 AYTVDWI 194
VDWI
Sbjct: 218 CNYVDWI 224
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 84.7 bits (208), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 59/187 (31%), Positives = 83/187 (44%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G K SCQGDSGGP++ L GIVS GY CA PG+Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKSSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPGVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 84.3 bits (207), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 15/191 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
+V+V LG++ I E + R I HP ++ D+ +++L +P +
Sbjct: 59 SRVEVRLGEHNIK-VTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTY 114
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+ P+ LP S LQ +++PI+ C +N
Sbjct: 115 VQPVALPTSCAPAGTMCTVSGWGNTMS--STADSNKLQCLNIPILSYSDC-----NNSYP 167
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
+I + M CAGY G KDSCQGDSGGP++ L G+VS GY CA+ G PG+Y +V
Sbjct: 168 GMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKV 223
Query: 188 AYTVDWISYIM 198
DW++ M
Sbjct: 224 CIFNDWLTSTM 234
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 84.0 bits (206), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 15/191 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
+V+V LG++ I E + R I HP ++ D+ +++L +P +
Sbjct: 44 SRVEVRLGEHNIK-VTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTY 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+ P+ LP S LQ +++PI+ C +N
Sbjct: 100 VQPVALPTSCAPAGTMCTVSGWGNTMS--STADSNKLQCLNIPILSYSDC-----NNSYP 152
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
+I + M CAGY G KDSCQGDSGGP++ L G+VS GY CA+ G PG+Y +V
Sbjct: 153 GMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKV 208
Query: 188 AYTVDWISYIM 198
DW++ M
Sbjct: 209 CIFNDWLTSTM 219
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 84.0 bits (206), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 15/191 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
+V+V LG++ I E + R I HP ++ D+ +++L +P +
Sbjct: 44 SRVEVRLGEHNIK-VTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTY 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+ P+ LP S LQ +++PI+ C +N
Sbjct: 100 VQPVALPTSCAPAGTMCTVSGWGNTMS--STADSNKLQCLNIPILSYSDC-----NNSYP 152
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
+I + M CAGY G KDSCQGDSGGP++ L G+VS GY CA+ G PG+Y +V
Sbjct: 153 GMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKV 208
Query: 188 AYTVDWISYIM 198
DW++ M
Sbjct: 209 CIFNDWLTSTM 219
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 84.0 bits (206), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 15/191 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
+V+V LG++ I E + R I HP ++ D+ +++L +P +
Sbjct: 64 SRVEVRLGEHNIK-VTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTY 119
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+ P+ LP S LQ +++PI+ C +
Sbjct: 120 VQPVALPTSCAPAGTMCTVSGWGNTMS--STADSNKLQCLNIPILSYSDCNNSYPG---- 173
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
+I + M CAGY G KDSCQGDSGGP++ L G+VS GY CA+ G PG+Y +V
Sbjct: 174 -MITNAMFCAGYLEGGKDSCQGDSGGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKV 228
Query: 188 AYTVDWISYIM 198
DW++ M
Sbjct: 229 CIFNDWLTSTM 239
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 83.6 bits (205), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 48/149 (32%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPI 111
D+ +++L +P ++ P+ LP S LQ +++PI
Sbjct: 84 DIMLIKLSKPATLNTYVQPVALPSSCAPAGTMCTVSGWGNTMS--STADGDKLQCLNIPI 141
Query: 112 IDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSA 171
+ C +N +I + M CAGY G KDSCQGDSGGP++ L G+VS
Sbjct: 142 LSYSDC-----NNSYPGMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGE----LQGVVSW 192
Query: 172 GYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
GY CA+ G PG+Y +V DW++ M T
Sbjct: 193 GYGCAEPGNPGVYAKVCIFNDWLTSTMAT 221
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 83.6 bits (205), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 57/192 (29%), Positives = 88/192 (45%), Gaps = 15/192 (7%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 68
+V+V LG++ I E + R I HP ++ D+ +++L +P ++
Sbjct: 45 RVEVRLGEHNI-KVTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTYV 100
Query: 69 APICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
P+ LP S LQ +++PI+ C +N
Sbjct: 101 QPVALPSSCAPAGTMCTVSGWGNTMS--STADKNKLQCLNIPILSYSDC-----NNSYPG 153
Query: 129 VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVA 188
+I + M CAGY G KDSCQGDSGGP++ L G+VS GY CA+ G PG+Y +V
Sbjct: 154 MITNAMFCAGYLEGGKDSCQGDSGGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKVC 209
Query: 189 YTVDWISYIMNT 200
+W++ M T
Sbjct: 210 IFNNWLTSTMAT 221
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 83.6 bits (205), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLXSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 83.6 bits (205), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 83.6 bits (205), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 15/191 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
+V+V LG++ I E + R I HP ++ D+ +++L +P +
Sbjct: 44 SRVEVRLGEHNIK-VTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKPATLNTY 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+ P+ LP S LQ +++PI+ C +
Sbjct: 100 VQPVALPTSCAPAGTMCTVSGWGNTMS--STADSDKLQCLNIPILSYSDCNDSYPG---- 153
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
+I + M CAGY G KDSCQGDSGGP++ L G+VS GY CA+ G PG+Y +V
Sbjct: 154 -MITNAMFCAGYLEGGKDSCQGDSGGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKV 208
Query: 188 AYTVDWISYIM 198
DW++ M
Sbjct: 209 CIFSDWLTSTM 219
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 83.2 bits (204), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNKRRKNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 83.2 bits (204), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 83.2 bits (204), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 9 QVQVTLGDYVINSAVEPLPAY-TFGVRKINVHPYFKFTPQADRY----DVAVLRLDRPVQ 63
Q +L ++ ++ VE L +R+++VHP ++ Q + Y D+A+L L+ V
Sbjct: 49 QSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYR---QDESYNFEGDIALLELENSVT 105
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKS 123
P++ PICLP+ D L+ V +P+ + + CE W +
Sbjct: 106 LGPNLLPICLPDN--DTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRG 163
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMME--RTGRWFLIGIVSAGYSCAQQGQP 181
V M CAG+ +D+CQGDSGG + T RW GIVS G C++
Sbjct: 164 KNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSR--GY 221
Query: 182 GIYHRVAYTVDWISYIM 198
G Y +V VDWI M
Sbjct: 222 GFYTKVLNYVDWIKKEM 238
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 83.2 bits (204), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 82.8 bits (203), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 51 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 106
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 107 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 160
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 161 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 216
Query: 190 TVDWI 194
V WI
Sbjct: 217 YVSWI 221
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 82.8 bits (203), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 82/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSTSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 82.8 bits (203), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 66 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 121
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 122 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 175
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 176 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 231
Query: 190 TVDWI 194
V WI
Sbjct: 232 YVSWI 236
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 82.8 bits (203), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 60 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 115
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 116 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 169
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 170 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 225
Query: 190 TVDWI 194
V WI
Sbjct: 226 YVSWI 230
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 82.8 bits (203), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 54/164 (32%), Positives = 80/164 (48%), Gaps = 11/164 (6%)
Query: 43 KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPK 102
+ P DV+V++ + + ++ PIC P+ D P
Sbjct: 82 NYDPATLENDVSVIKTAVAITFDINVGPICAPDPANDYVYRKSQCSGWGTINSGGVCCPA 141
Query: 103 TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGA--KDSCQGDSGGPL-MMER 159
L+ V + I N C+ + S+ IYD+M+CA G +DSCQGDSGGPL + +
Sbjct: 142 VLRYVTLNITTNAFCDAVYTSD----TIYDDMICATDNTGMTDRDSCQGDSGGPLSVKDG 197
Query: 160 TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNTATN 203
+G + L+GIVS G CA G PG+Y RV + WI+ +T TN
Sbjct: 198 SGIFSLVGIVSWGIGCA-SGYPGVYSRVGFHAGWIT---DTITN 237
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 82.8 bits (203), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 9 QVQVTLGDYVINSAVEPLPAY-TFGVRKINVHPYFKFTPQADRY----DVAVLRLDRPVQ 63
Q +L ++ ++ VE L +R+++VHP ++ Q + Y D+A+L L+ V
Sbjct: 138 QSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYR---QDESYNFEGDIALLELENSVT 194
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKS 123
P++ PICLP+ D L+ V +P+ + + CE W +
Sbjct: 195 LGPNLLPICLPDN--DTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRG 252
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMME--RTGRWFLIGIVSAGYSCAQQGQP 181
V M CAG+ +D+CQGDSGG + T RW GIVS G C++
Sbjct: 253 KNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSR--GY 310
Query: 182 GIYHRVAYTVDWISYIM 198
G Y +V VDWI M
Sbjct: 311 GFYTKVLNYVDWIKKEM 327
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 82.8 bits (203), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 52 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 107
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 108 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 161
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 162 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 217
Query: 190 TVDWI 194
V WI
Sbjct: 218 YVSWI 222
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 82.4 bits (202), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 9 QVQVTLGDYVINSAVEPLPAY-TFGVRKINVHPYFKFTPQADRY----DVAVLRLDRPVQ 63
Q +L ++ ++ VE L +R+++VHP ++ Q + Y D+A+L L+ V
Sbjct: 206 QSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYR---QDESYNFEGDIALLELENSVT 262
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKS 123
P++ PICLP+ D L+ V +P+ + + CE W +
Sbjct: 263 LGPNLLPICLPDN--DTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRG 320
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMME--RTGRWFLIGIVSAGYSCAQQGQP 181
V M CAG+ +D+CQGDSGG + T RW GIVS G C++
Sbjct: 321 KNRMDVFSQNMFCAGHPSLKQDACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSR--GY 378
Query: 182 GIYHRVAYTVDWISYIM 198
G Y +V VDWI M
Sbjct: 379 GFYTKVLNYVDWIKKEM 395
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 82.0 bits (201), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 56/185 (30%), Positives = 80/185 (43%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
+ LP + P L+ + PI+ + C+ +
Sbjct: 102 SVSLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVCAGK----LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 81.6 bits (200), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 66 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 121
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 122 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 175
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGD+GGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 176 ITSNMFCAGYLEGGKDSCQGDAGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 231
Query: 190 TVDWI 194
V WI
Sbjct: 232 YVSWI 236
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 81.6 bits (200), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHPSYDSNTLNN--DIMLIKLKSAASLDSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 81.3 bits (199), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 15/191 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
+V+V LG++ I E + R I HP ++ D+ +++L + +
Sbjct: 44 SRVEVRLGEHNIK-VTEGSEQFISSSRVIR-HP--NYSSYNIDNDIMLIKLSKSATLNTY 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+ P+ LP S LQ +++PI+ C +N
Sbjct: 100 VQPVALPSSCAPAGTMCTVSGWGNTMS--STADKNKLQCLNIPILSYSDC-----NNSYP 152
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
+I + M CAGY G KDSCQGDSGGP++ L G+VS GY CA+ G PG+Y +V
Sbjct: 153 GMITNAMFCAGYLEGGKDSCQGDSGGPVVCNGE----LQGVVSWGYGCAEPGNPGVYAKV 208
Query: 188 AYTVDWISYIM 198
DW++ M
Sbjct: 209 CIFNDWLTSTM 219
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 81.3 bits (199), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 82/187 (43%), Gaps = 14/187 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ IN +E + KI HP F + D+ +++L PV+
Sbjct: 44 SRIQVRLGEHNIN-VLEGNEQFV-NAAKIIKHP--NFDRKTLNNDIMLIKLSSPVKLNAR 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+A + LP P LQ +D P++ CE +
Sbjct: 100 VATVALPSSCAPAGTQCLISGWGNTLSSGVN-EPDLLQCLDAPLLPQADCEASYPGK--- 155
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
I D M+C G+ G K SCQGDSGGP++ L GIVS GY CA P +Y +V
Sbjct: 156 --ITDNMVCVGFLEGGKGSCQGDSGGPVVCNGE----LQGIVSWGYGCALPDNPDVYTKV 209
Query: 188 AYTVDWI 194
VDWI
Sbjct: 210 CNYVDWI 216
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 81.3 bits (199), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 14/197 (7%)
Query: 9 QVQVTLGDYVINSAVEPLPAY-TFGVRKINVHPYFKFTPQADRY----DVAVLRLDRPVQ 63
Q +L ++ ++ VE L +R+++VHP ++ Q + Y D+A+L L+ V
Sbjct: 138 QSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYR---QDESYNFEGDIALLELENSVT 194
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKS 123
P++ PICLP+ D L+ V +P+ + + CE W +
Sbjct: 195 LGPNLLPICLPDN--DTFYDLGLMGYVSGFGVMEEKIAHDLRFVRLPVANPQACENWLRG 252
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMME--RTGRWFLIGIVSAGYSCAQQGQP 181
V M CAG+ +D+CQGD+GG + T RW GIVS G C++
Sbjct: 253 KNRMDVFSQNMFCAGHPSLKQDACQGDAGGVFAVRDPNTDRWVATGIVSWGIGCSR--GY 310
Query: 182 GIYHRVAYTVDWISYIM 198
G Y +V VDWI M
Sbjct: 311 GFYTKVLNYVDWIKKEM 327
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 81.3 bits (199), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 82/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGD GGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDXGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 81.3 bits (199), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I ICLP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 80.9 bits (198), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I ICLP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 80.9 bits (198), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I ICLP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 80.9 bits (198), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I ICLP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 80.9 bits (198), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I ICLP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 80.9 bits (198), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I ICLP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 80.9 bits (198), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 82/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTS-XPDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAG G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGXLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 80.5 bits (197), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 82 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 139
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I ICLP D + L P+ L+ V +I +R+C++ H
Sbjct: 140 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHY---Y 196
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 197 GSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 256
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 257 VSHFLPWI 264
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 79.7 bits (195), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I ICLP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA D+CQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDACQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 79.0 bits (193), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 58/186 (31%), Positives = 83/186 (44%), Gaps = 15/186 (8%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM-PHI 68
+QV LG+ IN VE + + I VHP + D+ +++L +
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLXDSRV 101
Query: 69 APICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
A I LP + P L+ + PI+ + C+ +
Sbjct: 102 ASISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ---- 156
Query: 129 VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVA 188
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 157 -ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVC 211
Query: 189 YTVDWI 194
V WI
Sbjct: 212 NYVSWI 217
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 78.6 bits (192), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 7/94 (7%)
Query: 101 PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
P LQ +P++ N C+++ + I D M+CAG G SC GDSGGPL+ ++
Sbjct: 4 PDRLQQASLPLLSNTNCKKYWGTK-----IKDAMICAGASG--VSSCMGDSGGPLVCKKN 56
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
G W L+GIVS G S PG+Y RV V+W+
Sbjct: 57 GAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV 90
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 78.6 bits (192), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 7/94 (7%)
Query: 101 PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
P LQ +P++ N C+++ + I D M+CAG G SC GDSGGPL+ ++
Sbjct: 3 PDRLQQASLPLLSNTNCKKYWGTK-----IKDAMICAGASG--VSSCMGDSGGPLVCKKN 55
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
G W L+GIVS G S PG+Y RV V+W+
Sbjct: 56 GAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWV 89
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 78.2 bits (191), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 61/195 (31%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 16 DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE 75
++ N V+P P V KI +H K++ ++ D+A++++ PV I P CLP+
Sbjct: 68 EWGTNKPVKP-PLQERYVEKIIIHE--KYSASSEANDIALMKITPPVTCGHFIGPGCLPQ 124
Query: 76 --KGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCE--RWHKSNGINVVIY 131
G +R LQ V +ID C RW+ N I
Sbjct: 125 FRAGPPRVPQTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRWY-----NGRIR 179
Query: 132 DEMMCAGYRGGAKDSCQGDSGGPLMMERTGR--WFLIGIVSAGYSCAQQGQPGIYHRVAY 189
+CAGY G D+CQGDSGGPLM + + + ++GI S G CA+ +PG+Y
Sbjct: 180 STNVCAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVYTSTWS 239
Query: 190 TVDWI-SYIMNTATN 203
++WI S I +TA +
Sbjct: 240 YLNWIASKIGSTAVH 254
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 77.4 bits (189), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSAI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 77.4 bits (189), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGDSGGP++ +G+ L GIVS G CAQ+ +PGIY +V
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGIYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 77.4 bits (189), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 39/94 (41%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 101 PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
P LQ + P++ N C+ + I M+C G+ G KDSCQGDSGGP++
Sbjct: 7 PSLLQCLKAPVLSNSSCKSSYPGQ-----ITGNMICVGFLQGGKDSCQGDSGGPVVCNGQ 61
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
L GIVS GY CAQ+ +PG+Y +V V+WI
Sbjct: 62 ----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 91
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 77.4 bits (189), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I I LP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 77.0 bits (188), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGEGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 77.0 bits (188), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I I LP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 77.0 bits (188), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGDSGGP++ +G+ L GIVS G CAQ+ +PGIY +V
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGIYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 77.0 bits (188), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I I LP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 77.0 bits (188), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGDSGGP++ +G+ L GIVS G CAQ+ +PGIY +V
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDSGGPVVC--SGK--LQGIVSWGEGCAQKNKPGIYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 77.0 bits (188), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGFYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 77.0 bits (188), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I I LP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 77.0 bits (188), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I I LP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 77.0 bits (188), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I I LP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 77.0 bits (188), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSYI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 77.0 bits (188), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 58/188 (30%), Positives = 85/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 74 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 131
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I I LP D + L P+ L+ V +I +R+C++ H
Sbjct: 132 IQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 190
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGDSGGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 191 --EVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 248
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 249 VSHFLPWI 256
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 76.6 bits (187), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSWI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 76.6 bits (187), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 56/185 (30%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 76.6 bits (187), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 58/185 (31%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSASSR-----I 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KDSCQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDSCQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 76.6 bits (187), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 56/185 (30%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGDSGGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDSGGPVVC--SGK--LQGIVSWGEGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 76.3 bits (186), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 10/188 (5%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRL----DRPVQYMPH 67
V LG +NS + F V + +H + A D+A+L++ R Q
Sbjct: 59 VYLGRSRLNSNTQG--EMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERWHKSNGI 126
I I LP D + L P+ L+ V +I +R+C++ H
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGS- 175
Query: 127 NVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHR 186
+ +M+CA DSCQGD+GGPL+ GR L GIVS G CA + +PG+Y R
Sbjct: 176 --EVTTKMLCAADPQWKTDSCQGDAGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTR 233
Query: 187 VAYTVDWI 194
V++ + WI
Sbjct: 234 VSHFLPWI 241
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 15/175 (8%)
Query: 33 VRKINVHPYFKFTPQADRY---DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXX 89
+R+ YF + D D+ ++RL+RPV+ HIAP+ LP
Sbjct: 63 LRRFPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLPSNPPSVGSVCRIMGW 122
Query: 90 XXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQG 149
+ L P ++ I+D C+ +K + +CAG G KD+C+G
Sbjct: 123 GTITSPNATL-PDVPHCANINILDYAVCQAAYKG------LAATTLCAGILEGGKDTCKG 175
Query: 150 DSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQPGIYHRVAYTVDWISYIMNTATN 203
DSGGPL+ GI+S G + CAQ +PGIY +V DWI I++ T+
Sbjct: 176 DSGGPLICNGQ----FQGILSVGGNPCAQPRKPGIYTKVFDYTDWIQSIISGNTD 226
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 75.9 bits (185), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 56/185 (30%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGDSGGP++ +G+ L GIVS G CAQ+ +PG Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGFYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 75.1 bits (183), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGD+GGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDAGGPVVC--SGK--LQGIVSWGSGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 75.1 bits (183), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGD+GGP++ +G+ L GIVS G CAQ+ +PG+Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDAGGPVVC--SGK--LQGIVSWGEGCAQKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 75.1 bits (183), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 56/190 (29%), Positives = 87/190 (45%), Gaps = 15/190 (7%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++QV LG++ I+ +E + KI HP F + D+ +++L P
Sbjct: 47 SRIQVRLGEHNID-VLEGNEQF-INAAKIITHPNFNGNTLDN--DIMLIKLSSPATLNSR 102
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQ-AVDVPIIDNRQCERWHKSNGI 126
+A + LP P LQ ++ P++ + C+ +
Sbjct: 103 VATVSLPRSCAAAGTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSSYPGQ-- 160
Query: 127 NVVIYDEMMCAGYRGGAKDSC-QGDSGGPLMMERTGRWFLIGIVSAGYSC-AQQGQPGIY 184
I M+C G+ G KDSC QGDSGGP++ G+ L GIVS GY C AQ+ +PG+Y
Sbjct: 161 ---ITGNMICVGFLEGGKDSCSQGDSGGPVVCSN-GQ--LQGIVSWGYGCSAQKNKPGVY 214
Query: 185 HRVAYTVDWI 194
+V V+WI
Sbjct: 215 TKVCNYVNWI 224
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 75.1 bits (183), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 54/191 (28%), Positives = 85/191 (44%), Gaps = 19/191 (9%)
Query: 10 VQVTLGDYVI--NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++V LG++ I N E + + +R HP ++ D+ +++L +P +
Sbjct: 46 LRVRLGEHHIRVNEGTEQYISSSSVIR----HP--NYSSYNINNDIMLIKLTKPATLNQY 99
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+ + LP E S LQ + +PI+ + C +N
Sbjct: 100 VHAVALPT--ECAADATMCTVSGWGNTMSSVADGDKLQCLSLPILSHADC-----ANSYP 152
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
+I M CAGY G KDSCQGDSGGP++ L G+VS GY CA++ PG+Y +V
Sbjct: 153 GMITQSMFCAGYLEGGKDSCQGDSGGPVVCNG----VLQGVVSWGYGCAERDHPGVYAKV 208
Query: 188 AYTVDWISYIM 198
W+ M
Sbjct: 209 CVLSGWVRDTM 219
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 75.1 bits (183), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 101 PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
P LQ + P++ + C+ + I M+C G+ G KDSCQGDSGGP++
Sbjct: 7 PSLLQCLKAPVLSDSSCKSSYPGQ-----ITGNMICVGFLEGGKDSCQGDSGGPVVCNGQ 61
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
L GIVS GY CAQ+ +PG+Y +V V+WI
Sbjct: 62 ----LQGIVSWGYGCAQKNKPGVYTKVCNYVNWI 91
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 74.7 bits (182), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGDSGGP++ +G+ L GIVS G CAQ+ +PG Y ++
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDSGGPVVC--SGK--LQGIVSWGSGCAQKNKPGFYTKLCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 74.3 bits (181), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGD+GGP++ +G+ L GIVS G CAQ+ +PG Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDAGGPVVC--SGK--LQGIVSWGSGCAQKNKPGFYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 74.3 bits (181), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 83/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAGY G KD+CQGD+GGP++ +G+ L GIVS G CAQ+ +PG Y +V
Sbjct: 156 ITSNMFCAGYLEGGKDACQGDAGGPVVC--SGK--LQGIVSWGEGCAQKNKPGFYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 74.3 bits (181), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 5 ASARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQY 64
+S+R +V LG + + S EP + V K+ VH + ++ D+A+L+L PV
Sbjct: 48 SSSRTYRVVLGRHSL-STNEP-GSLAVKVSKLVVHQDWNSNQLSNGNDIALLKLASPVSL 105
Query: 65 MPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCER--WHK 122
I CLP G + P LQ + ++D C + W
Sbjct: 106 TDKIQLGCLPAAGTILPNNYVCYVTGWGRLQTNGASPDILQQGQLLVVDYATCSKPGWWG 165
Query: 123 SNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMME-RTGRWFLIGIVSAGYS--CAQQG 179
S + M+CAG G SC GDSGGPL + G+W + GIVS G S C
Sbjct: 166 S-----TVKTNMICAG-GDGIISSCNGDSGGPLNCQGANGQWQVHGIVSFGSSLGCNYYH 219
Query: 180 QPGIYHRVAYTVDWISYIM 198
+P ++ RV+ +DWI+ ++
Sbjct: 220 KPSVFTRVSNYIDWINSVI 238
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 74.3 bits (181), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 82/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLXSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M C GY G KD+CQGDSGGP++ +G+ L GIVS G CAQ+ +PG Y +V
Sbjct: 156 ITSNMFCVGYLEGGKDACQGDSGGPVVC--SGK--LQGIVSWGEGCAQKNKPGFYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 73.9 bits (180), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 55/185 (29%), Positives = 82/185 (44%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSETYNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + + + +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSS-----CKSASSFI 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M C GY G KD+CQGDSGGP++ +G+ L GIVS G CAQ+ +PG Y +V
Sbjct: 156 ITSNMFCVGYLEGGKDACQGDSGGPVVC--SGK--LQGIVSWGEGCAQKNKPGFYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 73.9 bits (180), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 59/182 (32%), Positives = 83/182 (45%), Gaps = 14/182 (7%)
Query: 20 NSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPE--KG 77
N V+P P V +I +H K+ + D+A++++ PV P I P CLP+ G
Sbjct: 72 NKPVKP-PLQERFVEEIIIHE--KYVSGLEINDIALIKITPPVPCGPFIGPGCLPQFKAG 128
Query: 78 EDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCE--RWHKSNGINVVIYDEMM 135
TLQ V +ID C RW+ N I +
Sbjct: 129 PPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWY-----NGRIRSTNV 183
Query: 136 CAGYRGGAKDSCQGDSGGPLMM-ERTGRWF-LIGIVSAGYSCAQQGQPGIYHRVAYTVDW 193
CAGY G D+CQGDSGGPLM +R F ++GI S G CA+ +PG+Y ++W
Sbjct: 184 CAGYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTSTWPYLNW 243
Query: 194 IS 195
I+
Sbjct: 244 IA 245
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 73.6 bits (179), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 83/186 (44%), Gaps = 14/186 (7%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 68
++QV LG++ I +E + KI HP ++ + D+ +++L H+
Sbjct: 45 RIQVRLGEHNI-EVLEGNEQF-INAAKIIRHP--QYDRKTLNNDIMLIKLSSRAVINAHV 100
Query: 69 APICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
+ I LP + P LQ +D P++ +CE +
Sbjct: 101 STISLPTAPPATGTKCLISGWGNTASSGADY-PDELQCLDAPVLSQAKCEASYPGK---- 155
Query: 129 VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVA 188
I M C G+ G KDSCQGD+GGP++ L G+VS G CAQ+ +PG+Y +V
Sbjct: 156 -ITSNMFCVGFLEGGKDSCQGDAGGPVVCNGQ----LQGVVSWGDGCAQKNKPGVYTKVY 210
Query: 189 YTVDWI 194
V WI
Sbjct: 211 NYVKWI 216
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 73.2 bits (178), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 39/99 (39%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 101 PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
P+ LQ +PI+ C++ S I D M CAG G DSC GDSGGPL+ ++
Sbjct: 6 PEKLQQAALPIVSEADCKKSWGSK-----ITDVMTCAGASG--VDSCMGDSGGPLVCQKD 58
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
G W L GIVS G PG+Y RV + W+ I+
Sbjct: 59 GVWTLAGIVSWGSGVCSTSTPGVYSRVTALMPWVQQILE 97
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 73.2 bits (178), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 38/94 (40%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 101 PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
P LQ +D P++ +CE + I M C G+ G KDSCQGDSGGP++
Sbjct: 132 PDELQCLDAPVLSQAKCEASYPGK-----ITSNMFCVGFLEGGKDSCQGDSGGPVVCNGQ 186
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
L G+VS G CAQ+ +PG+Y +V V WI
Sbjct: 187 ----LQGVVSWGDGCAQKNKPGVYTKVYNYVKWI 216
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 6/169 (3%)
Query: 32 GVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXX 91
GV+KI VHPY+ A YD+A+LRL + V ++ LP G
Sbjct: 73 GVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCYITGW 132
Query: 92 XXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDS 151
+ +TLQ +P +D C S+ + + M+CAG G + CQGDS
Sbjct: 133 GLTRTNGQLAQTLQQAYLPTVDYAICS---SSSYWGSTVKNSMVCAG-GDGVRSGCQGDS 188
Query: 152 GGPLMMERTGRWFLIGIVS--AGYSCAQQGQPGIYHRVAYTVDWISYIM 198
GGPL G++ + G+ S + C +P ++ RV+ + WI+ ++
Sbjct: 189 GGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVI 237
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 6/169 (3%)
Query: 32 GVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXX 91
GV+KI VHPY+ A YD+A+LRL + V ++ LP G
Sbjct: 73 GVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILANNSPCYITGW 132
Query: 92 XXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDS 151
+ +TLQ +P +D C S+ + + M+CAG G + CQGDS
Sbjct: 133 GLTRTNGQLAQTLQQAYLPTVDYAICS---SSSYWGSTVKNSMVCAG-GDGVRSGCQGDS 188
Query: 152 GGPLMMERTGRWFLIGIVS--AGYSCAQQGQPGIYHRVAYTVDWISYIM 198
GGPL G++ + G+ S + C +P ++ RV+ + WI+ ++
Sbjct: 189 GGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVI 237
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 72.8 bits (177), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 6/169 (3%)
Query: 32 GVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXX 91
GV+KI VHPY+ A YD+A+LRL + V ++ LP G
Sbjct: 73 GVQKIVVHPYWNTDDVAAGYDIALLRLAQSVTLNSYVQLGVLPRAGTILRNNSPCYITGW 132
Query: 92 XXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDS 151
+ +TLQ +P +D C S+ + + M+CAG G + CQGDS
Sbjct: 133 GLTRTNGQLAQTLQQAYLPTVDYAICS---SSSYWGSTVKNSMVCAG-GDGVRSGCQGDS 188
Query: 152 GGPLMMERTGRWFLIGIVS--AGYSCAQQGQPGIYHRVAYTVDWISYIM 198
GGPL G++ + G+ S + C +P ++ RV+ + WI+ ++
Sbjct: 189 GGPLHCLVNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINNVI 237
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 72.0 bits (175), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 10/105 (9%)
Query: 100 RPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GGAKDSCQGDSGGPLM 156
+P LQ V++PI++ C+ + + I D M CAGY+ G D+C+GDSGGP +
Sbjct: 2 QPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFV 56
Query: 157 MER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 57 MKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 101
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 71.6 bits (174), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 10/105 (9%)
Query: 100 RPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GGAKDSCQGDSGGPLM 156
+P LQ V++PI++ C+ + + I D M CAGY+ G D+C+GDSGGP +
Sbjct: 2 QPSVLQVVNLPIVERPVCK-----DSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFV 56
Query: 157 MER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 57 MKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 101
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 71.6 bits (174), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 14/186 (7%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 68
++QV LG++ I +E + V+ I HP K+ D+ +++L P +
Sbjct: 45 RIQVRLGEHNI-KVLEGNEQFINAVKIIR-HP--KYNRDTLDNDIMLIKLSSPAVINARV 100
Query: 69 APICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
+ I LP + P L+ +D P++ +C+ +
Sbjct: 101 STISLPTAPPAAGTECLISGWGNTLSFGADY-PDELKCLDAPVLTQAECKASYPGK---- 155
Query: 129 VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVA 188
I + M C G+ G KDSCQ DSGGP++ L G+VS G+ CA + +PG+Y +V
Sbjct: 156 -ITNSMFCVGFLEGGKDSCQRDSGGPVVCNGQ----LQGVVSWGHGCAWKNRPGVYTKVY 210
Query: 189 YTVDWI 194
VDWI
Sbjct: 211 NYVDWI 216
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 71.2 bits (173), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 56/185 (30%), Positives = 81/185 (43%), Gaps = 17/185 (9%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CAG GG DSCQGDSGGP++ +G+ L GIVS G CA+ +PG+Y +V
Sbjct: 156 ITSNMFCAGLEGG--DSCQGDSGGPVVC--SGK--LQGIVSWGSGCAKN-KPGVYTKVCN 208
Query: 190 TVDWI 194
V WI
Sbjct: 209 YVSWI 213
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 71.2 bits (173), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 38/99 (38%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 101 PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
P+ LQ +PI+ C++ S I D M CAG G DSC GDSGGPL+ ++
Sbjct: 6 PEKLQQAALPIVSEADCKKSWGSK-----ITDVMTCAGASG--VDSCMGDSGGPLVCQKD 58
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
G W L GIVS G P +Y RV + W+ I+
Sbjct: 59 GVWTLAGIVSWGSGVCSTSTPAVYSRVTALMPWVQQILE 97
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 71.2 bits (173), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 57/195 (29%), Positives = 87/195 (44%), Gaps = 14/195 (7%)
Query: 5 ASARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQY 64
A+ +VQV LG + + S EP +R + P+ + P +D+ +L+L
Sbjct: 46 AADGKVQVLLGAHSL-SQPEPSKRLYDVLRAV---PHPDYQPDTIDHDLLLLQLSEKATL 101
Query: 65 MPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSN 124
P + P+ D + RP +LQ V +P++D C R +
Sbjct: 102 GPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHD 161
Query: 125 GINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQPGI 183
G I + +MCA +DSC+GDSGGPL+ L G+VS G C + +PGI
Sbjct: 162 G---AITERLMCA--ESNRRDSCKGDSGGPLVCGG----VLEGVVSWGSRVCGNRKKPGI 212
Query: 184 YHRVAYTVDWISYIM 198
Y RVA WI ++
Sbjct: 213 YTRVASYAAWIDSVL 227
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 70.9 bits (172), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 31 FGVRKINVHPYFKFTPQADRYD--VAVLRL----DRPVQYMPHIAPICLPEKGEDXXXXX 84
F V K VH F D YD +A+L+L R Q + +CLP D
Sbjct: 77 FEVEKYIVHKEF----DDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPA--DLQLPD 130
Query: 85 XXXXXXXXXXXXSRLRP---KTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAG-YR 140
L P + L+ V + + +C H +N + D M+CAG R
Sbjct: 131 WTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHL---LNRTVTDNMLCAGDTR 187
Query: 141 GGA-----KDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
G D+CQGDSGGPL+ GR L+GI+S G C Q+ PG+Y +V +DWI
Sbjct: 188 SGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWI 246
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 70.9 bits (172), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 16/196 (8%)
Query: 5 ASARQVQVTLGDYVINSAVEPLPAY-TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQ 63
A+ +VQV LG + ++ +P P+ + V + HP + P +D+ +L+L
Sbjct: 46 AADGKVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDSQ--PDTIDHDLLLLQLSEKAT 100
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKS 123
P + P+ D + RP +LQ V +P++D C R
Sbjct: 101 LGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHH 160
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQPG 182
+G I + +MCA +DSC+GDSGGPL+ L G+V++G + C + +PG
Sbjct: 161 DG---AITERLMCA--ESNRRDSCKGDSGGPLVCG----GVLEGVVTSGSAVCGNRKKPG 211
Query: 183 IYHRVAYTVDWISYIM 198
IY RVA WI ++
Sbjct: 212 IYTRVASYAAWIDSVL 227
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 70.9 bits (172), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 58/179 (32%), Positives = 79/179 (44%), Gaps = 24/179 (13%)
Query: 31 FGVRKINVHPYFKFTPQADRYD--VAVLRL----DRPVQYMPHIAPICLPEKGEDXXXXX 84
F V K VH F D YD +A+L+L R Q + +CLP D
Sbjct: 90 FEVEKYIVHKEF----DDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPA--DLQLPD 143
Query: 85 XXXXXXXXXXXXSRLRP---KTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAG-YR 140
L P + L+ V + + +C H +N + D M+CAG R
Sbjct: 144 WTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHL---LNRTVTDNMLCAGDTR 200
Query: 141 GGA-----KDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
G D+CQGDSGGPL+ GR L+GI+S G C Q+ PG+Y +V +DWI
Sbjct: 201 SGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWI 259
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 70.9 bits (172), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 10/108 (9%)
Query: 97 SRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR---GGAKDSCQGDSGG 153
+ ++P LQ V++P+++ C+ + I D M CAGY+ G D+C+GDSGG
Sbjct: 3 AEVQPSVLQVVNLPLVERPVCK-----ASTRIRITDNMFCAGYKPGEGKRGDACEGDSGG 57
Query: 154 PLMMER--TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
P +M+ RW+ +GIVS G C + G+ G Y V WI +++
Sbjct: 58 PFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVID 105
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 70.5 bits (171), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 48/166 (28%), Positives = 68/166 (40%), Gaps = 12/166 (7%)
Query: 30 TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXX 89
T + + VHP + + D+A+L+L + +I L G D
Sbjct: 66 TSSLSSVRVHPSYS----GNNNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVA 121
Query: 90 X-XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQ 148
P L V VPI+ C + ++ I ++M CAG G KDSCQ
Sbjct: 122 GWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTS----AITNQMFCAGVSSGGKDSCQ 177
Query: 149 GDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GDSGGP++ LIG VS G CA+ G+Y V +I
Sbjct: 178 GDSGGPIVDSSN---TLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 70.5 bits (171), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 48/166 (28%), Positives = 68/166 (40%), Gaps = 12/166 (7%)
Query: 30 TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXX 89
T + + VHP + + D+A+L+L + +I L G D
Sbjct: 66 TSSLSSVRVHPSYS----GNNNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVA 121
Query: 90 X-XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQ 148
P L V VPI+ C + ++ I ++M CAG G KDSCQ
Sbjct: 122 GWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTS----AITNQMFCAGVSSGGKDSCQ 177
Query: 149 GDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GDSGGP++ LIG VS G CA+ G+Y V +I
Sbjct: 178 GDSGGPIVDSSN---TLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 70.1 bits (170), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 5 ASARQVQVTLGDYVINSAVEPLPAY-TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQ 63
A+ +VQV LG + ++ +P P+ + V + HP + P +D+ +L+L
Sbjct: 46 AADGKVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDSQ--PDTIDHDLLLLQLSEKAT 100
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKS 123
P + P+ D + RP +LQ V +P++D C R
Sbjct: 101 LGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHH 160
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQPG 182
+G I + +MCA +DSC+GDSGGPL+ L G+V++G C + +PG
Sbjct: 161 DG---AITERLMCA--ESNRRDSCKGDSGGPLVCG----GVLEGVVTSGSRVCGNRKKPG 211
Query: 183 IYHRVAYTVDWISYIM 198
IY RVA WI ++
Sbjct: 212 IYTRVASYAAWIDSVL 227
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 70.1 bits (170), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 5 ASARQVQVTLGDYVINSAVEPLPAY-TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQ 63
A+ +VQV LG + ++ +P P+ + V + HP + P +D+ +L+L
Sbjct: 53 AADGKVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDSQ--PDTIDHDLLLLQLSEKAT 107
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKS 123
P + P+ D + RP +LQ V +P++D C R
Sbjct: 108 LGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHH 167
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQPG 182
+G I + +MCA +DSC+GDSGGPL+ L G+V++G C + +PG
Sbjct: 168 DG---AITERLMCA--ESNRRDSCKGDSGGPLVCG----GVLEGVVTSGSRVCGNRKKPG 218
Query: 183 IYHRVAYTVDWISYIM 198
IY RVA WI ++
Sbjct: 219 IYTRVASYAAWIDSVL 234
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 70.1 bits (170), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 14/196 (7%)
Query: 5 ASARQVQVTLGDY---VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRP 61
+++R QV LG+Y V+ + + +P + VHP + A D+A+++L R
Sbjct: 46 STSRTYQVVLGEYDRSVLEGSEQVIP---INAGDLFVHPLWNSNCVACGNDIALVKLSRS 102
Query: 62 VQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWH 121
Q + LP G+ P LQ +P +D C +W
Sbjct: 103 AQLGDKVQLANLPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQQALLPTVDYEHCSQW- 161
Query: 122 KSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT-GRWFLIGIVS--AGYSCAQQ 178
+ + + M+CAG G + C GDSGGPL G W + G+ S + + C
Sbjct: 162 --DWWGITVKKTMVCAG--GDTRSGCNGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTI 217
Query: 179 GQPGIYHRVAYTVDWI 194
+P ++ RV+ +DWI
Sbjct: 218 KKPTVFTRVSAFIDWI 233
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 69.7 bits (169), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 14/186 (7%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 68
++QV LG++ N V KI HP K+ D+ +++L P +
Sbjct: 45 RIQVRLGEH--NIKVLEGNEQFINAAKIIRHP--KYNRDTLDNDIMLIKLSSPAVINARV 100
Query: 69 APICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
+ I LP + P L+ +D P++ +C+ +
Sbjct: 101 STISLPTAPPAAGTECLISGWGNTLSFGADY-PDELKCLDAPVLTQAECKASYPGK---- 155
Query: 129 VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVA 188
I + M C G+ G KDSCQ D+GGP++ L G+VS G+ CA + +PG+Y +V
Sbjct: 156 -ITNSMFCVGFLEGGKDSCQRDAGGPVVCNGQ----LQGVVSWGHGCAWKNRPGVYTKVY 210
Query: 189 YTVDWI 194
VDWI
Sbjct: 211 NYVDWI 216
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 69.7 bits (169), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 14/186 (7%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 68
++QV LG++ N V KI HP K+ D+ +++L P +
Sbjct: 45 RIQVRLGEH--NIKVLEGNEQFINAAKIIRHP--KYNRDTLDNDIMLIKLSSPAVINARV 100
Query: 69 APICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
+ I LP + P L+ +D P++ +C+ +
Sbjct: 101 STISLPTAPPAAGTECLISGWGNTLSFGADY-PDELKCLDAPVLTQAECKASYPGK---- 155
Query: 129 VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVA 188
I + M C G+ G KDSCQ D+GGP++ L G+VS G+ CA + +PG+Y +V
Sbjct: 156 -ITNSMFCVGFLEGGKDSCQRDAGGPVVCNGQ----LQGVVSWGHGCAWKNRPGVYTKVY 210
Query: 189 YTVDWI 194
VDWI
Sbjct: 211 NYVDWI 216
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 69.7 bits (169), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 16/196 (8%)
Query: 5 ASARQVQVTLGDYVINSAVEPLPAY-TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQ 63
A+ +VQV LG + ++ +P P+ + V + HP + P +D+ +L+L
Sbjct: 46 AADGKVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDSR--PDTIDHDLLLLQLSEKAT 100
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKS 123
P + P+ D + RP LQ V +P++D C R
Sbjct: 101 LGPAVRPLPWQRVDRDVEPGTLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHH 160
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQPG 182
+G I MMCA +DSC+GDSGGPL+ L G+V++G C + +PG
Sbjct: 161 DG---AITQRMMCA--ESNRRDSCKGDSGGPLVCG----GVLEGVVTSGSRVCGNRKKPG 211
Query: 183 IYHRVAYTVDWISYIM 198
IY RVA WI ++
Sbjct: 212 IYTRVASYAAWIDSVL 227
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 69.3 bits (168), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 57/187 (30%), Positives = 83/187 (44%), Gaps = 25/187 (13%)
Query: 27 PAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLP------EKGEDX 80
P G+ K +H K+ + +D+A+L+L+R V + HI PICLP EK E
Sbjct: 200 PVVNVGIEKHLIHE--KYDARHIMHDIALLKLNRSVPFQKHIKPICLPITDELKEKAEQI 257
Query: 81 XXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR 140
S + LQA +VP+ C + ++ + +C G
Sbjct: 258 STYFVTGWGTTENGSSSDV---LLQA-NVPLQPRSACSQAYRR-----AVPLSQLCVG-G 307
Query: 141 GGAKDSCQGDSGGPL------MMERTGRWFLIGIVSAG-YSCAQQGQPGIYHRVAYTVDW 193
G +DSC+GDSGGPL + E + GIVS G +C Q PG+Y V V W
Sbjct: 308 GDLQDSCKGDSGGPLQAPAQYLGEYAPKMVEFGIVSQGVVTCGQISLPGLYTNVGEYVQW 367
Query: 194 ISYIMNT 200
I+ M +
Sbjct: 368 ITDTMAS 374
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 69.3 bits (168), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 6/99 (6%)
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGY-RGGAKDSCQGDSGGPLM-MERTG 161
L +VP + + C +S+ +++ +EM+CAGY G D+CQGDSGGP+ +
Sbjct: 135 LLKANVPFVSDAAC----RSSSSFILVANEMICAGYPDTGGVDTCQGDSGGPMFRKDNAD 190
Query: 162 RWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
W +GIVS GY CA+ G PG+Y V+ I+ T
Sbjct: 191 EWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAART 229
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 68.9 bits (167), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++ QV LG + I EP ++ PY + P D+ +L+L + +
Sbjct: 46 KRSQVILGAHSITRE-EPTKQIMLVKKEF---PYPCYDPATREGDLKLLQLTEKAKINKY 101
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+ + LP+KG+D S TL+ V++ IID + C + N N
Sbjct: 102 VTILHLPKKGDDVKPGTMCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYN-FN 160
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS--CAQQGQPGIYH 185
VI M+CAG G +DSC GDSG PL+ E R G+ S G C PG+Y
Sbjct: 161 PVIGMNMVCAGSLRGGRDSCNGDSGSPLLCEGVFR----GVTSFGLENKCGDPRGPGVYI 216
Query: 186 RVAYT-VDWISYIMNTA 201
++ ++WI + A
Sbjct: 217 LLSKKHLNWIIMTIKGA 233
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 68.9 bits (167), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 5 ASARQVQVTLGDYVINSAVEPLPAY-TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQ 63
A+ +VQV LG + ++ +P P+ + V + HP + P +D+ +L+L
Sbjct: 46 AADGKVQVLLGAHSLS---QPEPSKRLYDVLRAVPHPDSQ--PDTIDHDLLLLQLSEKAT 100
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKS 123
P + P+ D + RP +LQ V +P++D C R
Sbjct: 101 LGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHH 160
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQPG 182
+G I + +MCA +DSC+GD+GGPL+ L G+V++G C + +PG
Sbjct: 161 DG---AITERLMCA--ESNRRDSCKGDAGGPLVCG----GVLEGVVTSGSRVCGNRKKPG 211
Query: 183 IYHRVAYTVDWISYIM 198
IY RVA WI ++
Sbjct: 212 IYTRVASYAAWIDSVL 227
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 68.9 bits (167), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 55/190 (28%), Positives = 84/190 (44%), Gaps = 12/190 (6%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPH 67
++ QV LG + I EP ++ PY + P D+ +L+L + +
Sbjct: 46 KRSQVILGAHSITRE-EPTKQIMLVKKEF---PYPCYDPATREGDLKLLQLTEKAKINKY 101
Query: 68 IAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGIN 127
+ + LP+KG+D S TL+ V++ IID + C + N N
Sbjct: 102 VTILHLPKKGDDVKPGTMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYN-FN 160
Query: 128 VVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS--CAQQGQPGIYH 185
VI M+CAG G +DSC GDSG PL+ E R G+ S G C PG+Y
Sbjct: 161 PVIGMNMVCAGSLRGGRDSCNGDSGSPLLCEGVFR----GVTSFGLENKCGDPRGPGVYI 216
Query: 186 RVAYT-VDWI 194
++ ++WI
Sbjct: 217 LLSKKHLNWI 226
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 68.6 bits (166), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 67/166 (40%), Gaps = 12/166 (7%)
Query: 30 TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXX 89
T + + VHP + + D+A+L+L + +I L G D
Sbjct: 66 TSSLSSVRVHPSYS----GNNNDLAILKLSTSIPSGGNIGYARLAASGSDPVAGSSATVA 121
Query: 90 X-XXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQ 148
P L V VPI+ C + ++ I ++M CAG G KDSCQ
Sbjct: 122 GWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTS----AITNQMFCAGVSSGGKDSCQ 177
Query: 149 GDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
GD GGP++ LIG VS G CA+ G+Y V +I
Sbjct: 178 GDXGGPIVDSSN---TLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 68.6 bits (166), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 53/185 (28%), Positives = 78/185 (42%), Gaps = 14/185 (7%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG+ IN VE + + I VHP + D+ +++L +A
Sbjct: 46 IQVRLGEDNIN-VVEGNEQFISASKSI-VHP--SYNSNTLNNDIMLIKLKSAASLNSRVA 101
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
I LP + P L+ + PI+ + C+ +
Sbjct: 102 SISLPTSCASAGTQCLISGWGNTKSSGTSY-PDVLKCLKAPILSDSSCKSAYPGQ----- 155
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAY 189
I M CA G DSCQGDSGGP++ +G+ L GIVS G C + +PG+Y +V
Sbjct: 156 ITSNMFCAYGLEGKGDSCQGDSGGPVVC--SGK--LQGIVSWGSGCQAKNKPGVYTKVCN 211
Query: 190 TVDWI 194
V WI
Sbjct: 212 YVSWI 216
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 68.2 bits (165), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 17/180 (9%)
Query: 21 SAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDX 80
S P P + + + ++ +F D+ +LRL +P + PI LP E+
Sbjct: 69 SKAIPHPGFNMSLMRKHI----RFLEYDYSNDLMLLRLSKPADITDTVKPITLPT--EEP 122
Query: 81 XXXXXXXXXXXXXXXXSRLR-PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGY 139
++ + L V++ ++ N C + H + D M+CAG
Sbjct: 123 KLGSTCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAKAHIEK-----VTDAMLCAGE 177
Query: 140 RGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQPGIYHRVAYTVDWISYIM 198
G KD+C+GDSGGPL+ + L GI S G++ C + PG+Y ++ WI M
Sbjct: 178 MDGGKDTCKGDSGGPLICDGV----LQGITSWGHTPCGEPDMPGVYTKLNKFTSWIKDTM 233
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 67.8 bits (164), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 14/197 (7%)
Query: 5 ASARQVQVTLGDY---VINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRP 61
+++R QV LG+Y V+ + + +P + VHP + A D+A+++L R
Sbjct: 59 STSRTYQVVLGEYDRSVLQGSEQVIP---INAGDLFVHPLWNSNCVACGNDIALVKLSRS 115
Query: 62 VQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWH 121
Q + LP G+ P LQ +P++D C ++
Sbjct: 116 AQLGDKVQLANLPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHCSQY- 174
Query: 122 KSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT-GRWFLIGIVS--AGYSCAQQ 178
+ + + M+CAG G + C GDSGGPL G W + G+ S + + C
Sbjct: 175 --DWWGITVKKTMVCAG--GDTRSGCDGDSGGPLNCPAADGSWQVHGVTSFVSAFGCNTI 230
Query: 179 GQPGIYHRVAYTVDWIS 195
+P ++ RV+ +DWI+
Sbjct: 231 KKPTVFTRVSAFIDWIN 247
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 67.8 bits (164), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 9/195 (4%)
Query: 6 SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM 65
SAR +V LG++ +N+ T V + +H + A YD+A+LRL+
Sbjct: 49 SARTWRVVLGEHNLNTNEGKEQIMT--VNSVFIHSGWNSDDVAGGYDIALLRLNTQASLN 106
Query: 66 PHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNG 125
+ LP + +L+ +P +D+ C S
Sbjct: 107 SAVQLAALPPSNQILPNNNPCYITGWGKTSTGGPLSDSLKQAWLPSVDHATCS---SSGW 163
Query: 126 INVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVS--AGYSCAQQGQPGI 183
+ M+CAG GGA C GDSGGPL + G +++ G+ S + C +P +
Sbjct: 164 WGSTVKTTMVCAG--GGANSGCNGDSGGPLNCQVNGSYYVHGVTSFVSSSGCNASKKPTV 221
Query: 184 YHRVAYTVDWISYIM 198
+ RV+ + W++ IM
Sbjct: 222 FTRVSAYISWMNGIM 236
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 67.0 bits (162), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLM-MERTGR 162
L +VP + + C +S+ +++ +EM+CAGY +D+CQGDSGGP+ +
Sbjct: 135 LLKANVPFVSDAAC----RSSSSFILVANEMICAGYDTKQEDTCQGDSGGPMFRKDNADE 190
Query: 163 WFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
W +GIVS G CA++G+ G+Y V+ I+ T
Sbjct: 191 WVQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAART 228
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 67.0 bits (162), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 5/98 (5%)
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLM-MERTGR 162
L +VP + + C +S+ +++ +EM+CAGY +D+CQGDSGGP+ +
Sbjct: 130 LLKANVPFVSDAAC----RSSSSFILVANEMICAGYDTKQEDTCQGDSGGPMFRKDNADE 185
Query: 163 WFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
W +GIVS G CA++G+ G+Y V+ I+ T
Sbjct: 186 WVQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAART 223
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 66.6 bits (161), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 45/148 (30%), Positives = 65/148 (43%), Gaps = 11/148 (7%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPI 111
D+ +L L P + I LP K E + LQ V++ +
Sbjct: 94 DLMLLHLSEPADITGGVKVIDLPTK-EPKVGSTCLASGWGSTNPSEMVVSHDLQCVNIHL 152
Query: 112 IDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSA 171
+ N +C +K N + D M+CAG G KD+C GDSGGPL+ + L GI S
Sbjct: 153 LSNEKCIETYKDN-----VTDVMLCAGEMEGGKDTCAGDSGGPLICDG----VLQGITSG 203
Query: 172 GYS-CAQQGQPGIYHRVAYTVDWISYIM 198
G + CA+ P IY ++ WI +M
Sbjct: 204 GATPCAKPKTPAIYAKLIKFTSWIKKVM 231
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 66.6 bits (161), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 15/185 (8%)
Query: 11 QVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAP 70
+V LG Y ++ E GV+ I P+ ++ D+ +++L+R ++ + P
Sbjct: 49 RVRLGHYSLSPVYESGQQMFQGVKSI---PHPGYSHPGHSNDLMLIKLNRRIRPTKDVRP 105
Query: 71 ICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVI 130
I + PK LQ +++ ++ ++CE + I
Sbjct: 106 INVSSHCPSAGTKCLVSGWGTTKSPQVHF-PKVLQCLNISVLSQKRCEDAYPRQ-----I 159
Query: 131 YDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAG-YSCAQQGQPGIYHRVAY 189
D M CAG + G +DSCQGDSGGP++ + L G+VS G Y CA+ +PG+Y +
Sbjct: 160 DDTMFCAGDKAG-RDSCQGDSGGPVVCNGS----LQGLVSWGDYPCARPNRPGVYTNLCK 214
Query: 190 TVDWI 194
WI
Sbjct: 215 FTKWI 219
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 79/176 (44%), Gaps = 17/176 (9%)
Query: 36 INVHPYFKF--TPQADRY---DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXX 90
+ +HP +K P+ D+A++RL PV+ P ++PICLP D
Sbjct: 153 VFIHPGWKLLAVPEGRTNFDNDIALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLI 212
Query: 91 XX-XXXXSRLRPKTLQAVDVPIIDNRQCERWH----KSNGINVVIYDEMMCAGYRGGAKD 145
R R L+A +P+ R+C+ ++ V M+CAG G D
Sbjct: 213 SGWGRTEKRDRAVRLKAARLPVAPLRKCKEVKVEKPTADAEAYVFTPNMICAGGEKGM-D 271
Query: 146 SCQGDSGGPLMMERTG---RWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
SC+GDSGG ++ +++ G+VS G C G G+Y RV VDWI M
Sbjct: 272 SCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQC---GTYGLYTRVKNYVDWIMKTM 324
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 66.2 bits (160), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 1 MTNTASARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDR 60
++NT + R V LG + E Y GV I VH K+ R D+A+++L
Sbjct: 60 ISNTLTYR---VALGKNNLEVEDEAGSLYV-GVDTIFVHE--KWNSFLVRNDIALIKLAE 113
Query: 61 PVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERW 120
V+ I CLP +G + LQ P++D C
Sbjct: 114 TVELGDTIQVACLPSEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQPVVDYATCS-- 171
Query: 121 HKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVS--AGYSCAQQ 178
+ + + + M+CAG G +C GDSGGPL + G+W + GIVS +G SC
Sbjct: 172 -QRDWWGTTVKETMVCAG-GDGVISACNGDSGGPLNCQADGQWDVRGIVSFGSGLSCNTF 229
Query: 179 GQPGIYHRVAYTVDWIS 195
+P ++ RV+ +DWI+
Sbjct: 230 KKPTVFTRVSAYIDWIN 246
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 66.2 bits (160), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 66/147 (44%), Gaps = 11/147 (7%)
Query: 50 RYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLR-PKTLQAVD 108
+D+ +LRL P + + + LP + + P +Q V
Sbjct: 7 SHDLMLLRLQSPAKITDAVKVLELPTQEPELGSTCEASGWGSIEPGPDDFEFPDEIQCVQ 66
Query: 109 VPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGI 168
+ ++ N C H + + M+CAGY G KD+C GDSGGPL+ G W GI
Sbjct: 67 LTLLQNTFCADAHPDK-----VTESMLCAGYLPGGKDTCMGDSGGPLIC--NGMW--QGI 117
Query: 169 VSAGYS-CAQQGQPGIYHRVAYTVDWI 194
S G++ C +P IY ++ + +DWI
Sbjct: 118 TSWGHTPCGSANKPSIYTKLIFYLDWI 144
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 65.9 bits (159), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/176 (28%), Positives = 72/176 (40%), Gaps = 18/176 (10%)
Query: 24 EPLPAYTFGVRKINVHPYFKFTPQADR---YDVAVLRLDRPVQYMPHIAPICLPEKGEDX 80
E P F + + H T QAD +D+ +LRL P + + E
Sbjct: 70 ESFPHPGFNMSLLENH-----TRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPE 124
Query: 81 XXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYR 140
+ P LQ VD+ I+ N +C++ H + D M+C G+
Sbjct: 125 VGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQK-----VTDFMLCVGHL 179
Query: 141 GGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGY-SCAQQGQPGIYHRVAYTVDWIS 195
G KD+C GDSGGPLM + L G+ S GY C +P + RV V WI
Sbjct: 180 EGGKDTCVGDSGGPLMCDGV----LQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIE 231
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 65.9 bits (159), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/198 (27%), Positives = 84/198 (42%), Gaps = 23/198 (11%)
Query: 8 RQVQVTLGDYVINSAVEPLPAYTFGVRKINVHP-YFKFTPQADRYDVAVLRLDRPVQYMP 66
++ V LGD+ + S +P V + HP Y P+ +D+ ++RL
Sbjct: 45 QKYSVRLGDHSLQSRDQP--EQEIQVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGD 102
Query: 67 HIAPICL----PEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHK 122
+ P+ L P+ G+ P TL +V I +CER +
Sbjct: 103 KVKPVQLANLCPKVGQKCIISGWGTVTSPQENF-----PNTLNCAEVKIYSQNKCERAYP 157
Query: 123 SNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQP 181
I + M+CAG GA D+CQGDSGGPL+ + L GI S G C + +P
Sbjct: 158 GK-----ITEGMVCAGSSNGA-DTCQGDSGGPLVCDG----MLQGITSWGSDPCGKPEKP 207
Query: 182 GIYHRVAYTVDWISYIMN 199
G+Y ++ WI M+
Sbjct: 208 GVYTKICRYTTWIKKTMD 225
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 65.9 bits (159), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 72/176 (40%), Gaps = 20/176 (11%)
Query: 33 VRKINVHPYFKFT--------PQAD-RYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXX 83
V K HP F + P AD D+ +LRL +P + PI LP K E
Sbjct: 68 VSKSFPHPGFNMSLLMLQTIPPGADFSDDLMLLRLSKPADITDVVKPIALPTK-EPKPGS 126
Query: 84 XXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGA 143
+P LQ V + ++ N C + + + D M+CAG GG
Sbjct: 127 KCLASGWGSITPTRWQKPDDLQCVFITLLPNENCAKVYLQK-----VTDVMLCAGEMGGG 181
Query: 144 KDSCQGDSGGPLMMERTGRWFLIGIVSAG-YSCAQQGQPGIYHRVAYTVDWISYIM 198
KD+C+ DSGGPL+ + L G S G C + G P IY + WI M
Sbjct: 182 KDTCRDDSGGPLICDG----ILQGTTSYGPVPCGKPGVPAIYTNLIKFNSWIKDTM 233
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 65.5 bits (158), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 50/177 (28%), Positives = 77/177 (43%), Gaps = 19/177 (10%)
Query: 26 LPAYTFGVRKINVHPYFKFTPQ-ADRY--DVAVLRLDRPVQYMPHIAPICLPEKGEDXXX 82
+P F + +N H TPQ D Y D+ +LRL +P + PI LP + E
Sbjct: 75 IPHPDFNMSLLNEH-----TPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTE-EPKLG 128
Query: 83 XXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGG 142
P LQ V++ ++ N C++ H+ + + D M+CAG G
Sbjct: 129 STCLASGWGSTTPIKFKYPDDLQCVNLKLLPNEDCDKAHE-----MKVTDAMLCAGEMDG 183
Query: 143 AKDSCQGDSGGPLMMERTGRWFLIGIVSAG-YSCAQQGQPGIYHRVAYTVDWISYIM 198
+C+ DSGGPL+ + L GI S G C + +P +Y ++ WI M
Sbjct: 184 GSYTCEHDSGGPLICDG----ILQGITSWGPEPCGEPTEPSVYTKLIKFSSWIRETM 236
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 65.5 bits (158), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 13/157 (8%)
Query: 43 KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPK 102
KF D+ D+ ++RL RPV Y HIAP+ LP + + P
Sbjct: 80 KFPNGLDK-DIMLIRLRRPVTYSTHIAPVSLPSRSRGVGSRCRIMGWGKIS---TTTYPD 135
Query: 103 TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGR 162
++ I+ ++ CE + V +CAG G +D+C GDSGGPL+
Sbjct: 136 VPHCTNIFIVKHKWCEPLYPW----VPADSRTLCAGILKGGRDTCHGDSGGPLICNGE-- 189
Query: 163 WFLIGIVSAGYS-CAQQGQPGIYHRVAYTVDWISYIM 198
+ GIV+ G C Q +P +Y +V +WI I+
Sbjct: 190 --MHGIVAGGSEPCGQHLKPAVYTKVFDYNNWIQSII 224
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 65.5 bits (158), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGY-RGGAKDSCQGDSGGPLM-MERTG 161
L +VP + + C + N ++ +E +CAGY G D+CQGDSGGP+ +
Sbjct: 128 LLKANVPFVSDAACRSAYG----NELVANEEICAGYPDTGGVDTCQGDSGGPMFRKDNAD 183
Query: 162 RWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
W +GIVS GY CA+ G PG+Y V+ I+ T
Sbjct: 184 EWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAART 222
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 65.1 bits (157), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLM-MERTGR 162
L +VP + + C + N ++ +E +CAGY G D+CQGDSGGP+ +
Sbjct: 128 LLKANVPFVSDAACRSAYG----NELVANEEICAGYDTGGVDTCQGDSGGPMFRKDNADE 183
Query: 163 WFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
W +GIVS G CA++G+ G+Y V+ I+ T
Sbjct: 184 WIQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAART 221
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGY-RGGAKDSCQGDSGGPLM-MERTG 161
L +VP + + C + N ++ +E +CAGY G D+CQGDSGGP+ +
Sbjct: 128 LLKANVPFVSDAACRSAYG----NELVANEEICAGYPDTGGVDTCQGDSGGPMFRKDNAD 183
Query: 162 RWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
W +GIVS GY CA+ G PG+Y V+ I+ T
Sbjct: 184 EWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAART 222
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 64.7 bits (156), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 44/144 (30%), Positives = 65/144 (45%), Gaps = 11/144 (7%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPI 111
D+ +++LD+P+ HIAP+ LP + P ++ +
Sbjct: 85 DIMLIKLDKPISNSKHIAPLSLPSN-PPSVGSVCRIMGWGSITIPNETYPDVPYCANINL 143
Query: 112 IDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSA 171
+D C+ + N + +CAG G KD+C GDSGGPL+ + GIVS
Sbjct: 144 VDYEVCQGAY-----NGLPAKTTLCAGVLEGGKDTCVGDSGGPLICNGQFQ----GIVSY 194
Query: 172 G-YSCAQQGQPGIYHRVAYTVDWI 194
G +SC Q +PGIY V DWI
Sbjct: 195 GAHSCGQGPKPGIYTNVFDYTDWI 218
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 64.7 bits (156), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 86/198 (43%), Gaps = 12/198 (6%)
Query: 5 ASARQVQVTLGDYVINSAVEPLPAYTF-GVRKINVHPYFKFTPQADRYDVAVLRLDRPVQ 63
++ R +V +G N VE F GV I+VH ++ R D+A+++L V+
Sbjct: 48 SNTRTYRVAVGKN--NLEVEDEEGSLFVGVDTIHVHK--RWNALLLRNDIALIKLAEHVE 103
Query: 64 YMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKS 123
I CLPEK + LQ P++D+ C R
Sbjct: 104 LSDTIQVACLPEKDSLLPKDYPCYVTGWGRLWTNGPIADKLQQGLQPVVDHATCSR---I 160
Query: 124 NGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMME-RTGRWFLIGIVSAGY--SCAQQGQ 180
+ + M+CAG G +C GDSGGPL + G W + GIVS G C + +
Sbjct: 161 DWWGFRVKKTMVCAG-GDGVISACNGDSGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKK 219
Query: 181 PGIYHRVAYTVDWISYIM 198
P +Y RV+ +DWI+ M
Sbjct: 220 PVVYTRVSAYIDWINEKM 237
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 64.7 bits (156), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 39/98 (39%), Positives = 57/98 (58%), Gaps = 7/98 (7%)
Query: 100 RPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLM-ME 158
R +LQ +V +I N C +++ N EM CAG G+ D+C+GDSGGPL+ M+
Sbjct: 462 RVFSLQWGEVKLISN--CSKFYG----NRFYEKEMECAGTYDGSIDACKGDSGGPLVCMD 515
Query: 159 RTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISY 196
++ G+VS G +C + PG+Y +VA DWISY
Sbjct: 516 ANNVTYVWGVVSWGENCGKPEFPGVYTKVANYFDWISY 553
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 64.3 bits (155), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 36/99 (36%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGY-RGGAKDSCQGDSGGPLM-MERTG 161
L +VP + + C + N ++ +E +CAGY G D CQGDSGGP+ +
Sbjct: 128 LLKANVPFVSDAACRSAYG----NELVANEEICAGYPDTGGVDPCQGDSGGPMFRKDNAD 183
Query: 162 RWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
W +GIVS GY CA+ G PG+Y V+ I+ T
Sbjct: 184 EWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAART 222
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 63.5 bits (153), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 50/174 (28%), Positives = 71/174 (40%), Gaps = 20/174 (11%)
Query: 31 FGVRKINVHPYFKFTPQADRY---------DVAVLRLDRPVQYMPHIAPICLPEKGEDXX 81
F V HP + + +R+ D+ +LRL P + + + LP + E
Sbjct: 66 FQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKVMDLPTQ-EPAL 124
Query: 82 XXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRG 141
L PK LQ VD+ +I N C + H + M+CAG
Sbjct: 125 GTTCYASGWGSIEPEEFLTPKKLQCVDLHVISNDVCAQVHPQK-----VTKFMLCAGRWT 179
Query: 142 GAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQPGIYHRVAYTVDWI 194
G K +C GDSGGPL+ L GI S G CA +P +Y +V + WI
Sbjct: 180 GGKSTCSGDSGGPLVCNGV----LQGITSWGSEPCALPERPSLYTKVVHYRKWI 229
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 63.5 bits (153), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 12/190 (6%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 68
Q+++ LG + ++S P TF ++ HP +K P + D+A+L+LD V+ I
Sbjct: 49 QLRLVLGLHTLDS-----PGLTFHIKAAIQHPRYKPVPALEN-DLALLQLDGKVKPSRTI 102
Query: 69 APICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
P+ LP K + + L+ +D+ ++D R C NG
Sbjct: 103 RPLALPSKRQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNG--- 159
Query: 129 VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVS-AGYSCAQQGQPGIYHRV 187
+ M+C + C+GDSGGPL+ + GR L G++S + C +P + V
Sbjct: 160 SLSPSMVCLAADSKDQAPCKGDSGGPLVCGK-GR-VLAGVLSFSSRVCTDIFKPPVATAV 217
Query: 188 AYTVDWISYI 197
A V WI +
Sbjct: 218 APYVSWIRKV 227
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 62.8 bits (151), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 46/148 (31%), Positives = 67/148 (45%), Gaps = 17/148 (11%)
Query: 50 RYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDV 109
R DVA++ L P+++ + PI L ED P LQ +++
Sbjct: 85 RNDVALVHLTNPIKFNDLVQPIKLSTNDEDLESNPCTLTGWGSTRLGGN-TPNALQEIEL 143
Query: 110 PIIDNRQCER--WHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIG 167
+ +QCER W + D +C + G + +C GDSGGPL+ IG
Sbjct: 144 IVHPQKQCERDQWR--------VIDSHICTLTKRG-EGACHGDSGGPLVANGA----QIG 190
Query: 168 IVSAGYSCAQQGQPGIYHRVAYTVDWIS 195
IVS G CA G+P +Y RV+ V WI+
Sbjct: 191 IVSFGSPCA-LGEPDVYTRVSSFVSWIN 217
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 62.8 bits (151), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 10/99 (10%)
Query: 101 PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
P L VDV +I + C + +K ++ + M+CAG K++C GDSGGPL+ T
Sbjct: 131 PSDLMCVDVKLISPQDCTKVYKD-----LLENSMLCAGIPDSKKNACNGDSGGPLVCRGT 185
Query: 161 GRWFLIGIVSAG-YSCAQQGQPGIYHRVAYTVDWISYIM 198
L G+VS G + C Q PG+Y +V WI+ M
Sbjct: 186 ----LQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTM 220
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 62.8 bits (151), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 10/99 (10%)
Query: 101 PKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERT 160
P L VDV +I + C + +K ++ + M+CAG K++C GDSGGPL+ T
Sbjct: 131 PSDLMCVDVKLISPQDCTKVYKD-----LLENSMLCAGIPDSKKNACNGDSGGPLVCRGT 185
Query: 161 GRWFLIGIVSAG-YSCAQQGQPGIYHRVAYTVDWISYIM 198
L G+VS G + C Q PG+Y +V WI+ M
Sbjct: 186 ----LQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTM 220
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 62.4 bits (150), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/200 (30%), Positives = 85/200 (42%), Gaps = 24/200 (12%)
Query: 9 QVQVTLG-DYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRY--DVAVLRL--DRP-- 61
Q++V LG Y + E TF V+K VH F D Y D+A+L+L D P
Sbjct: 70 QLKVVLGRTYRVKPGEE---EQTFKVKKYIVHKEF----DDDTYNNDIALLQLKSDSPQC 122
Query: 62 VQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSR-LRPKTLQAVDVPIIDNRQCERW 120
Q + ICLPE S + L+ V + + +C
Sbjct: 123 AQESDSVRAICLPEANLQLPDWTECELSGYGKHKSSSPFYSEQLKEGHVRLYPSSRCA-- 180
Query: 121 HKSNGINVVIYDEMMCAG-YRGG-----AKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS 174
N + + M+CAG R G D+CQGDSGGPL+ L+GI+S G
Sbjct: 181 -PKFLFNKTVTNNMLCAGDTRSGEIYPNVHDACQGDSGGPLVCMNDNHMTLLGIISWGVG 239
Query: 175 CAQQGQPGIYHRVAYTVDWI 194
C ++ PG+Y +V + WI
Sbjct: 240 CGEKDVPGVYTKVTNYLGWI 259
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 61.6 bits (148), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRW 163
L+ + I+ N +C + H+ V + + +CAG C+GD GGPL+ E+
Sbjct: 135 LRVAHLYIMGNEKCSQHHRGK---VTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMR 191
Query: 164 FLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
++G++ G CA +PGI+ RVAY WI I+ T
Sbjct: 192 MVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKIILT 228
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 61.6 bits (148), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRW 163
L+ + I+ N +C + H+ V + + +CAG C+GD GGPL+ E+
Sbjct: 135 LRVAHLYIMGNEKCSQHHRGK---VTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMR 191
Query: 164 FLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
++G++ G CA +PGI+ RVAY WI I+ T
Sbjct: 192 MVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKIILT 228
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 61.6 bits (148), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 12/190 (6%)
Query: 9 QVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHI 68
Q+++ LG + ++S P TF ++ HP +K P A ++A+L+LD V+ I
Sbjct: 49 QLRLVLGLHTLDS-----PGLTFHIKAAIQHPRYKPVP-ALENNLALLQLDGKVKPSRTI 102
Query: 69 APICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINV 128
P+ LP K + + L+ +D+ ++D R C NG
Sbjct: 103 RPLALPSKRQVVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNG--- 159
Query: 129 VIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVS-AGYSCAQQGQPGIYHRV 187
+ M+C + C+GDSGGPL+ + GR L G++S + C +P + V
Sbjct: 160 SLSPSMVCLAADSKDQAPCKGDSGGPLVCGK-GR-VLAGVLSFSSRVCTDIFKPPVATAV 217
Query: 188 AYTVDWISYI 197
A V WI +
Sbjct: 218 APYVSWIRKV 227
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 60.8 bits (146), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 52/186 (27%), Positives = 76/186 (40%), Gaps = 17/186 (9%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG + N + V + +HP + + D+ +LRL RP + I
Sbjct: 47 LQVFLGKH--NLGQQESSQEQSSVVRAVIHP--DYDAASHDQDIMLLRLARPAKLSELIQ 102
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
P+ L D P T+Q + ++ +CE +
Sbjct: 103 PLPLER---DCSAQTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQ----- 154
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAG-YSCAQQGQPGIYHRVA 188
I M+CAG KDSCQGDSGGPL+ L G+VS G C + +PG+Y V
Sbjct: 155 ITQNMLCAGDEKYGKDSCQGDSGGPLVCGD----HLRGLVSWGNIPCGSKEKPGVYTNVC 210
Query: 189 YTVDWI 194
+WI
Sbjct: 211 RYTNWI 216
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 60.8 bits (146), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 17/186 (9%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+QV LG + + E + VR + +HP + + D+ +LRL RP + I
Sbjct: 47 LQVFLGKHNLRQR-ESSQEQSSVVRAV-IHP--DYDAASHDQDIMLLRLARPAKLSELIQ 102
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
P+ L D P T+Q + ++ +CE +
Sbjct: 103 PLPLER---DCSANTTSCHILGWGKTADGDFPDTIQCAYIHLVSREECEHAYPGQ----- 154
Query: 130 IYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAG-YSCAQQGQPGIYHRVA 188
I M+CAG KDSCQGDSGGPL+ L G+VS G C + +PG+Y V
Sbjct: 155 ITQNMLCAGDEKYGKDSCQGDSGGPLVCGD----HLRGLVSWGNIPCGSKEKPGVYTNVC 210
Query: 189 YTVDWI 194
+WI
Sbjct: 211 RYTNWI 216
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 60.8 bits (146), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 7/146 (4%)
Query: 40 PYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRL 99
P+ + T D+ +++L + H+ + + K S L
Sbjct: 80 PFSRVTSDPQSNDIMLVKLQTAAKLNKHVKMLHIRSKTSLRSGTKCKVTGWGATDPDS-L 138
Query: 100 RPK-TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMME 158
RP TL+ V V ++ + C NG + I +M+CAG G KDSC+GD+GGPL+
Sbjct: 139 RPSDTLREVTVTVLSRKLCNSQSYYNG-DPFITKDMVCAGDAKGQKDSCKGDAGGPLIC- 196
Query: 159 RTGRWFLIGIVSAGYSCAQQGQPGIY 184
+ IVS G+ C +PGIY
Sbjct: 197 ---KGVFHAIVSGGHECGVATKPGIY 219
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 60.5 bits (145), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 46/158 (29%), Positives = 66/158 (41%), Gaps = 15/158 (9%)
Query: 38 VHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXS 97
+HP + + D+ +LRL RP + I P+ L D
Sbjct: 74 IHP--DYDAASHDQDIMLLRLARPAKLSELIQPLPLER---DCSAQTTSCHILGWGKTAD 128
Query: 98 RLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMM 157
P T+Q + ++ +CE + I M+CAG KDSCQGDSGGPL+
Sbjct: 129 GDFPDTIQCAYIHLVSREECEHAYPGQ-----ITQNMLCAGDEKYGKDSCQGDSGGPLVC 183
Query: 158 ERTGRWFLIGIVSAG-YSCAQQGQPGIYHRVAYTVDWI 194
L G+VS G C + +PG+Y V +WI
Sbjct: 184 GD----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWI 217
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 59.3 bits (142), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 47/144 (32%), Positives = 62/144 (43%), Gaps = 13/144 (9%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLR-PKTLQAVDVP 110
D+AV+RL PV IA + LP D S L L+ VDVP
Sbjct: 87 DIAVIRLPVPVTLTAAIATVGLPST--DVGVGTVVTPTGWGLPSDSALGISDVLRQVDVP 144
Query: 111 IIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVS 170
I+ N C+ + ++ D +C GG K +C GDSGGPL G + I
Sbjct: 145 IMSNADCDAVYG------IVTDGNICIDSTGG-KGTCNGDSGGPL--NYNGLTYGITSFG 195
Query: 171 AGYSCAQQGQPGIYHRVAYTVDWI 194
A C + G P + RV Y +DWI
Sbjct: 196 AAAGC-EAGYPDAFTRVTYFLDWI 218
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 58.2 bits (139), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 17/165 (10%)
Query: 44 FTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKT 103
F P D+ +++L + V + PICLP K D + +
Sbjct: 179 FHPDNSTVDIGLIKLKQKVPVNERVMPICLPSK--DYVNVGLVGYVSGWGRNANLNFTEH 236
Query: 104 LQAVDVPIIDNRQCERWHKSN------------GINVVIYDEMMCAGYRGGAKDSCQGDS 151
L+ V +P+ D +C ++++ + G+ ++ + CAG +D+C GD+
Sbjct: 237 LKYVMLPVADQEKCVQYYEGSTVPEKKTPKSPVGVQPILNEHTFCAGLSKYQEDTCYGDA 296
Query: 152 GGPLMM--ERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWI 194
G + + W+ GI+S SC + + G+Y RV +DWI
Sbjct: 297 GSAFAVHDKDDDTWYAAGILSFDKSC-RTAEYGVYVRVTSILDWI 340
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 56.2 bits (134), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 15/105 (14%)
Query: 98 RLRPKTLQAVDVPIIDNRQCE---RWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGP 154
+ P ++ I+D+ C W + + + +CAG G +D+C DSGGP
Sbjct: 131 EIYPDVPHCANINILDHAVCRTAYSWRQ-------VANTTLCAGILQGGRDTCHFDSGGP 183
Query: 155 LMMERTGRWFLIGIVS-AGYSCAQQGQPGIYHRVAYTVDWISYIM 198
L+ GIVS G+ C Q G+PG+Y +V +DWI I+
Sbjct: 184 LICNG----IFQGIVSWGGHPCGQPGEPGVYTKVFDYLDWIKSII 224
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 12/153 (7%)
Query: 44 FTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKT 103
F P DVA++++ V+Y +I PI LP GE+ S
Sbjct: 80 FNPDTYLNDVALIKIPH-VEYTDNIQPIRLP-SGEELNNKFENIWATVSGWGQSNTDTVI 137
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRW 163
LQ +IDN +C + + +I + +C G K C GDSGGP ++ + +
Sbjct: 138 LQYTYNLVIDNDRCAQEYPPG----IIVESTICGDTSDG-KSPCFGDSGGPFVL--SDKN 190
Query: 164 FLIGIVS--AGYSCAQQGQPGIYHRVAYTVDWI 194
LIG+VS +G C + G+P + RV +DWI
Sbjct: 191 LLIGVVSFVSGAGC-ESGKPVGFSRVTSYMDWI 222
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 39/159 (24%), Positives = 61/159 (38%), Gaps = 6/159 (3%)
Query: 40 PYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRL 99
P K + +L+L+R V +A ICLP + +
Sbjct: 73 PVAKMVCGPSGSQLVLLKLERSVTLNQRVALICLPPEWYVVPPGTKCEIAGWGETKGTG- 131
Query: 100 RPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMER 159
L + +I N++C H+ + + MC +C+GD GGPL
Sbjct: 132 NDTVLNVALLNVISNQECNIKHRGR-----VRESEMCTEGLLAPVGACEGDYGGPLACFT 186
Query: 160 TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
W L GI+ CA+ P ++ RV+ VDWI +M
Sbjct: 187 HNSWVLEGIIIPNRVCARSRWPAVFTRVSVFVDWIHKVM 225
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/144 (29%), Positives = 63/144 (43%), Gaps = 10/144 (6%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPI 111
D+ +++LD+P+ HIAP+ LP P ++ +
Sbjct: 86 DIMLIKLDKPISNSKHIAPLSLPSSPPSVGSVCRIMGWGSITPVKETF-PDVPYCANINL 144
Query: 112 IDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSA 171
+D+ C+ + ++ +CAG G KD+C GDSGGPL+ GIVS
Sbjct: 145 LDHAVCQAGYPE----LLAEYRTLCAGIVQGGKDTCGGDSGGPLICNGQ----FQGIVSY 196
Query: 172 G-YSCAQQGQPGIYHRVAYTVDWI 194
G + C Q +PGIY V DWI
Sbjct: 197 GAHPCGQGPKPGIYTNVFDYTDWI 220
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/144 (29%), Positives = 63/144 (43%), Gaps = 10/144 (6%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPI 111
D+ +++LD+P+ HIAP+ LP P ++ +
Sbjct: 86 DIMLIKLDKPISNSKHIAPLSLPSSPPSVGSVCRIMGWGSITPVKETF-PDVPYCANINL 144
Query: 112 IDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSA 171
+D+ C+ + ++ +CAG G KD+C GDSGGPL+ GIVS
Sbjct: 145 LDHAVCQAGYPE----LLAEYRTLCAGIVQGGKDTCGGDSGGPLICNGQ----FQGIVSY 196
Query: 172 G-YSCAQQGQPGIYHRVAYTVDWI 194
G + C Q +PGIY V DWI
Sbjct: 197 GAHPCGQGPKPGIYTNVFDYTDWI 220
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 41/169 (24%), Positives = 62/169 (36%), Gaps = 6/169 (3%)
Query: 30 TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXX 89
T V +H + + D+A+L L + +I LP +
Sbjct: 71 TANVDSYTMHENYGAGTASYSNDIAILHLATSISLGGNIQAAVLPANNNNDYAGTTCVIS 130
Query: 90 XXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQG 149
+ P LQ +P+I QC G I+D +C G +C G
Sbjct: 131 GWGRTDGTNNLPDILQKSSIPVITTAQCTAAMVGVG-GANIWDNHICVQDPAGNTGACNG 189
Query: 150 DSGGPLMMERTGRWFLIG----IVSAGYSCAQQGQPGIYHRVAYTVDWI 194
DSGGPL G ++G +VS+G P +Y RV+ + WI
Sbjct: 190 DSGGPLNCPDGGT-RVVGVTSWVVSSGLGACLPDYPSVYTRVSAYLGWI 237
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 44/157 (28%), Positives = 60/157 (38%), Gaps = 16/157 (10%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPI 111
D+ ++RLD PV+ HIA R+ P DVP
Sbjct: 88 DIMLIRLDSPVKNSKHIA-------PFSLPSSPPSVGSVCRIMGWGRISPTEGTYPDVPH 140
Query: 112 IDNRQCERWHKSNG----INVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIG 167
N + + +CAG G KD+C+GDSGGPL+ G
Sbjct: 141 CVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCKGDSGGPLICNGQ----FQG 196
Query: 168 IVSAGYS-CAQQGQPGIYHRVAYTVDWISYIMNTATN 203
I S G CAQ +P Y +V +DWI I+ T+
Sbjct: 197 IASWGDDPCAQPHKPAAYTKVFDHLDWIENIIAGNTD 233
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 28/65 (43%), Positives = 36/65 (55%), Gaps = 5/65 (7%)
Query: 131 YDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYS-CAQQGQPGIYHRVAY 189
+ M CAG KDSC GDSGGPL+ +L G+VS G + C Q G PG+Y +
Sbjct: 157 HPSMFCAGGGQDQKDSCNGDSGGPLICNG----YLQGLVSFGKAPCGQVGVPGVYTNLCK 212
Query: 190 TVDWI 194
+WI
Sbjct: 213 FTEWI 217
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 28/65 (43%), Positives = 37/65 (56%), Gaps = 5/65 (7%)
Query: 135 MCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAG-YSCAQQGQPGIYHRVAYTVDW 193
+CAG G KD+C GDSGGPL+ + GIVS G + C Q +PG+Y +V W
Sbjct: 164 LCAGILEGGKDTCGGDSGGPLICNGQFQ----GIVSFGAHPCGQGLKPGVYTKVFDYNHW 219
Query: 194 ISYIM 198
I I+
Sbjct: 220 IQSII 224
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 11/160 (6%)
Query: 40 PYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRL 99
P+ + P+ D+ +L+L+R ++ + P+ LP S L
Sbjct: 76 PHPAYNPKNFSNDIMLLQLERKAKWTTAVRPLRLPSSKAQVKPGQLCSVAGWGYVSMSTL 135
Query: 100 RPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMER 159
TLQ V + + + QCER N +C G + +GDSGGPL+ +
Sbjct: 136 -ATTLQEVLLTVQKDCQCERLFHGNYSRAT----EICVGDPKKTQTGFKGDSGGPLVCKD 190
Query: 160 TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
+ GI+S Y + PG+Y +V++ + WI M
Sbjct: 191 VAQ----GILS--YGNKKGTPPGVYIKVSHFLPWIKRTMK 224
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 48.5 bits (114), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 14/167 (8%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
V K +H + P + +D+ +L+L++ V+ P + + LP +
Sbjct: 72 VEKQIIHESYNSVP--NLHDIMLLKLEKKVELTPAVNVVPLPSPSDFIHPGAMCWAAGWG 129
Query: 93 XXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSG 152
TL+ V++ I+D + C + Y +C G + + GDSG
Sbjct: 130 KTGVRDPTSYTLREVELRIMDEKACVDYRYYE------YKFQVCVGSPTTLRAAFMGDSG 183
Query: 153 GPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
GPL+ GIVS G+ A+ P I+ RV+ V WI+ ++N
Sbjct: 184 GPLLCAGVAH----GIVSYGHPDAK--PPAIFTRVSTYVPWINAVIN 224
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 51/195 (26%), Positives = 76/195 (38%), Gaps = 18/195 (9%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
R + VTLG + I + E V K HP + P D+ +L+L R +
Sbjct: 48 GRSMTVTLGAHNIKAKEET--QQIIPVAKAIPHP--DYNPDDRSNDIMLLKLVRNAKRTR 103
Query: 67 HIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGI 126
+ P+ LP + PKTL V + + ++ CE +S+
Sbjct: 104 AVRPLNLPRRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSS-- 161
Query: 127 NVVIYDEM--MCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIY 184
Y+ +C G S +GDSGGPL+ +R GIVS G + P ++
Sbjct: 162 ----YNRANEICVGDSKIKGASFRGDSGGPLVCKRAA----AGIVSYGQT--DGSAPQVF 211
Query: 185 HRVAYTVDWISYIMN 199
RV V WI M
Sbjct: 212 TRVLSFVSWIKKTMK 226
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 47.4 bits (111), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 11/160 (6%)
Query: 40 PYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRL 99
P+ + P+ ++ +L+L+R ++ + P+ LP S L
Sbjct: 76 PHPAYNPKNFSNNIMLLQLERKAKWTTAVRPLRLPSSKAQVKPGQLCSVAGWGYVSMSTL 135
Query: 100 RPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMER 159
TLQ V + + + QCER N +C G + +GDSGGPL+ +
Sbjct: 136 -ATTLQEVLLTVQKDCQCERLFHGNYSRAT----EICVGDPKKTQTGFKGDSGGPLVCKD 190
Query: 160 TGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
+ GI+S Y + PG+Y +V++ + WI M
Sbjct: 191 VAQ----GILS--YGNKKGTPPGVYIKVSHFLPWIKRTMK 224
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 47.0 bits (110), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 37/151 (24%), Positives = 62/151 (41%), Gaps = 24/151 (15%)
Query: 46 PQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQ 105
P+ YDVA+++L ++Y I PICLP L + ++
Sbjct: 104 PEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIK 163
Query: 106 AVDVPIIDNR---------------QCER-------WHKSNGINVVIYDEMMCAGYRGGA 143
A+ V + + CER + K I+ V+ +C G
Sbjct: 164 ALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPY 223
Query: 144 KD--SCQGDSGGPLMMERTGRWFLIGIVSAG 172
D +C+GDSGGPL++ + R+ +G++S G
Sbjct: 224 ADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 254
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 47.0 bits (110), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 37/151 (24%), Positives = 62/151 (41%), Gaps = 24/151 (15%)
Query: 46 PQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQ 105
P+ YDVA+++L ++Y I PICLP L + ++
Sbjct: 303 PEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIK 362
Query: 106 AVDVPIIDNR---------------QCER-------WHKSNGINVVIYDEMMCAGYRGGA 143
A+ V + + CER + K I+ V+ +C G
Sbjct: 363 ALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPY 422
Query: 144 KD--SCQGDSGGPLMMERTGRWFLIGIVSAG 172
D +C+GDSGGPL++ + R+ +G++S G
Sbjct: 423 ADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 453
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 47.0 bits (110), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 37/151 (24%), Positives = 62/151 (41%), Gaps = 24/151 (15%)
Query: 46 PQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQ 105
P+ YDVA+++L ++Y I PICLP L + ++
Sbjct: 311 PEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIK 370
Query: 106 AVDVPIIDNR---------------QCER-------WHKSNGINVVIYDEMMCAGYRGGA 143
A+ V + + CER + K I+ V+ +C G
Sbjct: 371 ALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPY 430
Query: 144 KD--SCQGDSGGPLMMERTGRWFLIGIVSAG 172
D +C+GDSGGPL++ + R+ +G++S G
Sbjct: 431 ADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 461
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 47.0 bits (110), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 37/151 (24%), Positives = 62/151 (41%), Gaps = 24/151 (15%)
Query: 46 PQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQ 105
P+ YDVA+++L ++Y I PICLP L + ++
Sbjct: 545 PEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIK 604
Query: 106 AVDVPIIDNR---------------QCER-------WHKSNGINVVIYDEMMCAGYRGGA 143
A+ V + + CER + K I+ V+ +C G
Sbjct: 605 ALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPY 664
Query: 144 KD--SCQGDSGGPLMMERTGRWFLIGIVSAG 172
D +C+GDSGGPL++ + R+ +G++S G
Sbjct: 665 ADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 695
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 47.0 bits (110), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 37/151 (24%), Positives = 62/151 (41%), Gaps = 24/151 (15%)
Query: 46 PQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQ 105
P+ YDVA+++L ++Y I PICLP L + ++
Sbjct: 536 PEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIK 595
Query: 106 AVDVPIIDNR---------------QCER-------WHKSNGINVVIYDEMMCAGYRGGA 143
A+ V + + CER + K I+ V+ +C G
Sbjct: 596 ALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPY 655
Query: 144 KD--SCQGDSGGPLMMERTGRWFLIGIVSAG 172
D +C+GDSGGPL++ + R+ +G++S G
Sbjct: 656 ADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 686
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 47.0 bits (110), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 37/151 (24%), Positives = 62/151 (41%), Gaps = 24/151 (15%)
Query: 46 PQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQ 105
P+ YDVA+++L ++Y I PICLP L + ++
Sbjct: 555 PEFYDYDVALIKLKNKLKYGQTIRPICLPCTEGTTRALRLPPTTTCQQQKEELLPAQDIK 614
Query: 106 AVDVPIIDNR---------------QCER-------WHKSNGINVVIYDEMMCAGYRGGA 143
A+ V + + CER + K I+ V+ +C G
Sbjct: 615 ALFVSEEEKKLTRKEVYIKNGDKKGSCERDAQYAPGYDKVKDISEVVTPRFLCTGGVSPY 674
Query: 144 KD--SCQGDSGGPLMMERTGRWFLIGIVSAG 172
D +C+GDSGGPL++ + R+ +G++S G
Sbjct: 675 ADPNTCRGDSGGPLIVHKRSRFIQVGVISWG 705
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 46.6 bits (109), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 47/196 (23%), Positives = 81/196 (41%), Gaps = 14/196 (7%)
Query: 6 SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM 65
S ++QVTLG + I + V KI HP + ++ D+ +L+L +
Sbjct: 47 SGSKIQVTLGAHNIKE--QEKMQQIIPVVKIIPHPAYNSKTISN--DIMLLKLKSKAKRS 102
Query: 66 PHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNG 125
+ P+ LP + TLQ V++ + ++++CE + K
Sbjct: 103 SAVKPLNLPRRNVKVKPGDVCYVAGWGKLGPMGKYSDTLQEVELTVQEDQKCESYLK--- 159
Query: 126 INVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYH 185
N +CAG + S +GDSGGPL+ ++ GIVS G + P +
Sbjct: 160 -NYFDKANEICAGDPKIKRASFRGDSGGPLVCKKVA----AGIVSYGQN--DGSTPRAFT 212
Query: 186 RVAYTVDWISYIMNTA 201
+V+ + WI M +
Sbjct: 213 KVSTFLSWIKKTMKKS 228
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/192 (25%), Positives = 76/192 (39%), Gaps = 18/192 (9%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+ VTLG + I EP + R I P+ + P+ D+ +L+L+R + +
Sbjct: 50 INVTLGAHNIKEQ-EPTQQFIPVKRPI---PHPAYNPKNFSNDIMLLQLERKAKRTRAVQ 105
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
P+ LP TLQ V + + ++R+CE +
Sbjct: 106 PLRLPSNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRH------ 159
Query: 130 IYDEM--MCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
YD +C G K S +GDSGGPL+ + + GIVS G + P +V
Sbjct: 160 YYDSTIELCVGDPEIKKTSFKGDSGGPLVCNKVAQ----GIVSYGRNNGM--PPRACTKV 213
Query: 188 AYTVDWISYIMN 199
+ V WI M
Sbjct: 214 SSFVHWIKKTMK 225
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 49/192 (25%), Positives = 76/192 (39%), Gaps = 18/192 (9%)
Query: 10 VQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIA 69
+ VTLG + I EP + R I P+ + P+ D+ +L+L+R + +
Sbjct: 50 INVTLGAHNIKEQ-EPTQQFIPVKRPI---PHPAYNPKNFSNDIMLLQLERKAKRTRAVQ 105
Query: 70 PICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVV 129
P+ LP TLQ V + + ++R+CE +
Sbjct: 106 PLRLPSNKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRH------ 159
Query: 130 IYDEM--MCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRV 187
YD +C G K S +GDSGGPL+ + + GIVS G + P +V
Sbjct: 160 YYDSTIELCVGDPEIKKTSFKGDSGGPLVCNKVAQ----GIVSYGRNNGM--PPRACTKV 213
Query: 188 AYTVDWISYIMN 199
+ V WI M
Sbjct: 214 SSFVHWIKKTMK 225
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 50/195 (25%), Positives = 75/195 (38%), Gaps = 18/195 (9%)
Query: 7 ARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMP 66
R + VTLG + I + E V K HP + P D+ +L+L R +
Sbjct: 48 GRSMTVTLGAHNIKAKEET--QQIIPVAKAIPHP--DYNPDDRSNDIMLLKLVRNAKRTR 103
Query: 67 HIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGI 126
+ P+ LP + PKTL V + + ++ CE +S+
Sbjct: 104 AVRPLNLPRRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSS-- 161
Query: 127 NVVIYDEM--MCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIY 184
Y+ +C G S + DSGGPL+ +R GIVS G + P ++
Sbjct: 162 ----YNRANEICVGDSKIKGASFEEDSGGPLVCKRAA----AGIVSYGQT--DGSAPQVF 211
Query: 185 HRVAYTVDWISYIMN 199
RV V WI M
Sbjct: 212 TRVLSFVSWIKKTMK 226
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 43/166 (25%), Positives = 68/166 (40%), Gaps = 13/166 (7%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXX 92
VR+ HP + A+ D+ +L+L R ++PI LP +
Sbjct: 71 VRRPIPHPDYNDETLAN--DIMLLKLTRKADITDKVSPINLPRSLAEVKPGMMCSVAGWG 128
Query: 93 XXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSG 152
+ LQ VD+ + +C K N + + ++ CAG K+S GDSG
Sbjct: 129 RLGVNMPSTDKLQEVDLEVQSEEKCIARFK----NYIPFTQI-CAGDPSKRKNSFSGDSG 183
Query: 153 GPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
GPL+ + GIVS G + P +Y R++ + WI M
Sbjct: 184 GPLVCNGVAQ----GIVSYGRN--DGTTPDVYTRISSFLSWIHSTM 223
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 44.7 bits (104), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 44/193 (22%), Positives = 77/193 (39%), Gaps = 16/193 (8%)
Query: 6 SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM 65
+ R + VTLG + I E V K HP K+ +D+ +L+L
Sbjct: 47 AGRSITVTLGAHNITE--EEDTWQKLEVIKQFRHP--KYNTSTLHHDIMLLKLKEKASLT 102
Query: 66 PHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNG 125
+ + P + + TLQ V + ++D + C + +
Sbjct: 103 LAVGTLPFPSQKNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFD- 161
Query: 126 INVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYH 185
++ +C G K + +GDSGGPL+ + GIVS G S A+ P ++
Sbjct: 162 -----HNLQLCVGNPRKTKSAFKGDSGGPLLCAGAAQ----GIVSYGRSDAK--PPAVFT 210
Query: 186 RVAYTVDWISYIM 198
R+++ WI+ I+
Sbjct: 211 RISHYQPWINQIL 223
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 44.3 bits (103), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/193 (22%), Positives = 77/193 (39%), Gaps = 16/193 (8%)
Query: 6 SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM 65
+ R + VTLG + I E V K HP K+ +D+ +L+L
Sbjct: 47 AGRSITVTLGAHNITE--EEDTWQKLEVIKQFRHP--KYNTSTLHHDIMLLKLKEKASLT 102
Query: 66 PHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNG 125
+ + P + + TLQ V + ++D + C + +
Sbjct: 103 LAVGTLPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFD- 161
Query: 126 INVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYH 185
++ +C G K + +GDSGGPL+ + GIVS G S A+ P ++
Sbjct: 162 -----HNLQLCVGNPRKTKSAFKGDSGGPLLCAGAAQ----GIVSYGRSDAK--PPAVFT 210
Query: 186 RVAYTVDWISYIM 198
R+++ WI+ I+
Sbjct: 211 RISHYQPWINQIL 223
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 34/141 (24%), Positives = 59/141 (41%), Gaps = 21/141 (14%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPI 111
D+A+L+L + V+ H PICLP E L +++ A V +
Sbjct: 318 DIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVAL 377
Query: 112 ------IDNRQCERWHKS--------------NGINVVIYDEMMCAGYRGGAKDSCQGDS 151
I+ + W + V+ D+ +C+G + + C+G+S
Sbjct: 378 NGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQED-ESPCKGES 436
Query: 152 GGPLMMERTGRWFLIGIVSAG 172
GG + +ER R+F +G+VS G
Sbjct: 437 GGAVFLERRFRFFQVGLVSWG 457
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 44/193 (22%), Positives = 77/193 (39%), Gaps = 16/193 (8%)
Query: 6 SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM 65
+ R + VTLG + I E V K HP K+ +D+ +L+L
Sbjct: 47 AGRSITVTLGAHNITE--EEDTWQKLEVIKQFRHP--KYNTSTLHHDIMLLKLKEKASLT 102
Query: 66 PHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNG 125
+ + P + + TLQ V + ++D + C + +
Sbjct: 103 LAVGTLPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFD- 161
Query: 126 INVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYH 185
++ +C G K + +GDSGGPL+ + GIVS G S A+ P ++
Sbjct: 162 -----HNLQLCVGNPRKTKSAFKGDSGGPLLCAGVAQ----GIVSYGRSDAK--PPAVFT 210
Query: 186 RVAYTVDWISYIM 198
R+++ WI+ I+
Sbjct: 211 RISHYRPWINQIL 223
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 34/141 (24%), Positives = 59/141 (41%), Gaps = 21/141 (14%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPI 111
D+A+L+L + V+ H PICLP E L +++ A V +
Sbjct: 326 DIALLKLAQKVKMSTHARPICLPCTMEANLALRRPQGSTCRDHENELLNKQSVPAHFVAL 385
Query: 112 ------IDNRQCERWHKS--------------NGINVVIYDEMMCAGYRGGAKDSCQGDS 151
I+ + W + V+ D+ +C+G + + C+G+S
Sbjct: 386 NGSKLNINLKMGVEWTSCAEVVSQEKTMFPNLTDVREVVTDQFLCSGTQED-ESPCKGES 444
Query: 152 GGPLMMERTGRWFLIGIVSAG 172
GG + +ER R+F +G+VS G
Sbjct: 445 GGAVFLERRFRFFQVGLVSWG 465
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 18/42 (42%), Positives = 29/42 (69%), Gaps = 1/42 (2%)
Query: 35 KINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 76
KI +HP + + DR D+A+L+L RP++ +I P+CLP+K
Sbjct: 83 KIYIHPRYNWKENLDR-DIALLKLKRPIELSDYIHPVCLPDK 123
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 44/193 (22%), Positives = 77/193 (39%), Gaps = 16/193 (8%)
Query: 6 SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM 65
+ R + VTLG + I E V K HP K+ +D+ +L+L
Sbjct: 47 AGRSITVTLGAHNITE--EEDTWQKLEVIKQFRHP--KYNTSTLHHDIMLLKLKEKASLT 102
Query: 66 PHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNG 125
+ + P + + TLQ V + ++D + C + +
Sbjct: 103 LAVGTLPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFD- 161
Query: 126 INVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYH 185
++ +C G K + +GDSGGPL+ + GIVS G S A+ P ++
Sbjct: 162 -----HNLQLCVGNPRKTKSAFKGDSGGPLLCAGVAQ----GIVSYGRSDAK--PPAVFT 210
Query: 186 RVAYTVDWISYIM 198
R+++ WI+ I+
Sbjct: 211 RISHYRPWINQIL 223
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 43.9 bits (102), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 44/193 (22%), Positives = 77/193 (39%), Gaps = 16/193 (8%)
Query: 6 SARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYM 65
+ R + VTLG + I E V K HP K+ +D+ +L+L
Sbjct: 49 AGRSITVTLGAHNITE--EEDTWQKLEVIKQFRHP--KYNTSTLHHDIMLLKLKEKASLT 104
Query: 66 PHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNG 125
+ + P + + TLQ V + ++D + C + +
Sbjct: 105 LAVGTLPFPSQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFD- 163
Query: 126 INVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYH 185
++ +C G K + +GDSGGPL+ + GIVS G S A+ P ++
Sbjct: 164 -----HNLQLCVGNPRKTKSAFKGDSGGPLLCAGVAQ----GIVSYGRSDAK--PPAVFT 212
Query: 186 RVAYTVDWISYIM 198
R+++ WI+ I+
Sbjct: 213 RISHYRPWINQIL 225
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 30/44 (68%), Gaps = 1/44 (2%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 76
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++
Sbjct: 8 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDR 50
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 16/44 (36%), Positives = 30/44 (68%), Gaps = 1/44 (2%)
Query: 33 VRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEK 76
+ KI +HP + + DR D+A+++L +PV + +I P+CLP++
Sbjct: 81 LEKIYIHPRYNWRENLDR-DIALMKLKKPVAFSDYIHPVCLPDR 123
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 37/145 (25%), Positives = 60/145 (41%), Gaps = 11/145 (7%)
Query: 51 YDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVP 110
+D+ +LRL +P + + + LP + +R TLQ V++
Sbjct: 95 HDLMLLRLAQPARITDAVKILDLPTQEPKLGSTCYTSGWGLISTFTNR-GSGTLQCVELR 153
Query: 111 IIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVS 170
+ N +C R + V +CA +R + C GDSGG L+ + + GI S
Sbjct: 154 LQSNEKCARAYPEKMTEFV-----LCATHRDDSGSICLGDSGGALICDGVFQ----GITS 204
Query: 171 AGYS-CAQQGQPGIYHRVAYTVDWI 194
GYS CA ++ +V WI
Sbjct: 205 WGYSECADFNDNFVFTKVMPHKKWI 229
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 15/100 (15%)
Query: 103 TLQAVDVPIIDNRQCERWHKSNGINVVIYD--EMMCAGYRGGAKDSCQGDSGGPLMMERT 160
TL+ V + + +RQC R S YD +C G R K + +GDSGGPL+
Sbjct: 138 TLREVQLRVQRDRQCLRIFGS-------YDPRRQICVGDRRERKAAFKGDSGGPLLCNNV 190
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
GIVS G S P ++ RV+ + WI M +
Sbjct: 191 AH----GIVSYGKSSGV--PPEVFTRVSSFLPWIRTTMRS 224
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 41.2 bits (95), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 15/100 (15%)
Query: 103 TLQAVDVPIIDNRQCERWHKSNGINVVIYD--EMMCAGYRGGAKDSCQGDSGGPLMMERT 160
TL+ V + + +RQC R S YD +C G R K + +GDSGGPL+
Sbjct: 138 TLREVQLRVQRDRQCLRIFGS-------YDPRRQICVGDRRERKAAFKGDSGGPLLCNNV 190
Query: 161 GRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMNT 200
GIVS G S P ++ RV+ + WI M +
Sbjct: 191 AH----GIVSYGKSSGV--PPEVFTRVSSFLPWIRTTMRS 224
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 12/96 (12%)
Query: 103 TLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGR 162
TLQ V + I+D + C+ + + + +C G ++ +GDSGGPL+ +
Sbjct: 140 TLQEVKMRILDPQACKHFEDFH------QEPQLCVGNPKKIRNVYKGDSGGPLLCAGIAQ 193
Query: 163 WFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIM 198
GI A Y P ++ R+++ WI+ I+
Sbjct: 194 ----GI--ASYVLRNAKPPSVFTRISHYRPWINKIL 223
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 37.0 bits (84), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 41/200 (20%), Positives = 73/200 (36%), Gaps = 17/200 (8%)
Query: 2 TNTASARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRP 61
T S +T+ Y ++ +PL ++ +VH + ++ A D+++L L+ P
Sbjct: 92 TAKCSLLHRNITVKTYFNRTSQDPLM-----IKITHVHVHMRYDADAGENDLSLLELEWP 146
Query: 62 VQYMPHIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCER 119
+Q P+C PEK E + L +L V +++ +C
Sbjct: 147 IQCPGAGLPVCTPEKDFAEHLLIPRTRGLLSGWARNGTDL-GNSLTTRPVTLVEGEEC-- 203
Query: 120 WHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQG 179
+NV + C A G + E G WFL G++ + Q
Sbjct: 204 ---GQVLNVTVTTRTYCERSSVAAM---HWMDGSVVTREHRGSWFLTGVLGS-QPVGGQA 256
Query: 180 QPGIYHRVAYTVDWISYIMN 199
+ +V+ W IMN
Sbjct: 257 HMVLVTKVSRYSLWFKQIMN 276
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 36.6 bits (83), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 41/200 (20%), Positives = 73/200 (36%), Gaps = 17/200 (8%)
Query: 2 TNTASARQVQVTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRP 61
T S +T+ Y ++ +PL ++ +VH + ++ A D+++L L+ P
Sbjct: 133 TAKCSLLHRNITVKTYFNRTSQDPLM-----IKITHVHVHMRYDADAGENDLSLLELEWP 187
Query: 62 VQYMPHIAPICLPEK--GEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCER 119
+Q P+C PEK E + L +L V +++ +C
Sbjct: 188 IQCPGAGLPVCTPEKDFAEHLLIPRTRGLLSGWARNGTDL-GNSLTTRPVTLVEGEEC-- 244
Query: 120 WHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQG 179
+NV + C A G + E G WFL G++ + Q
Sbjct: 245 ---GQVLNVTVTTRTYCERSSVAAM---HWMDGSVVTREHRGSWFLTGVLGS-QPVGGQA 297
Query: 180 QPGIYHRVAYTVDWISYIMN 199
+ +V+ W IMN
Sbjct: 298 HMVLVTKVSRYSLWFKQIMN 317
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 36.2 bits (82), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 39/88 (44%), Gaps = 5/88 (5%)
Query: 104 LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRW 163
L + ++D + CE +K + IYD + CAG GD+G P + T
Sbjct: 139 LMEANFTVVDRKSCEEQYKQIEADKYIYDGVFCAGGEYDETYIGYGDAGDPAVQNGT--- 195
Query: 164 FLIGIVSAGYSCAQQGQPGIYHRVAYTV 191
L+G+ S S + P ++ RV Y V
Sbjct: 196 -LVGVASYISSMPSE-FPSVFLRVGYYV 221
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 34.3 bits (77), Expect = 0.049, Method: Compositional matrix adjust.
Identities = 43/188 (22%), Positives = 67/188 (35%), Gaps = 22/188 (11%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 71
V LG Y + E TF + ++ + Y PQ + D+ +L+LDR + +
Sbjct: 53 VVLGAYDLRRR-ERQSRQTFSISSMSENGY---DPQQNLNDLMLLQLDREANLTSSVTIL 108
Query: 72 CLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIY 131
LP + + + V+V + QC + G+
Sbjct: 109 PLPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVCTGVLT--- 165
Query: 132 DEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTV 191
RGG C GD G PL+ E G+ S +G P + RVA
Sbjct: 166 -------RRGGI---CNGDGGTPLVCE----GLAHGVASFSLGPCGRG-PDFFTRVALFR 210
Query: 192 DWISYIMN 199
DWI ++N
Sbjct: 211 DWIDGVLN 218
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 34.3 bits (77), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 43/188 (22%), Positives = 67/188 (35%), Gaps = 22/188 (11%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 71
V LG Y + E TF + ++ + Y PQ + D+ +L+LDR + +
Sbjct: 53 VVLGAYDLRRR-ERQSRQTFSISSMSENGY---DPQQNLNDLMLLQLDREANLTSSVTIL 108
Query: 72 CLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIY 131
LP + + + V+V + QC + G+
Sbjct: 109 PLPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVCTGVLT--- 165
Query: 132 DEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTV 191
RGG C GD G PL+ E G+ S +G P + RVA
Sbjct: 166 -------RRGGI---CNGDQGTPLVCE----GLAHGVASFSLGPCGRG-PDFFTRVALFR 210
Query: 192 DWISYIMN 199
DWI ++N
Sbjct: 211 DWIDGVLN 218
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 34.3 bits (77), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 43/188 (22%), Positives = 67/188 (35%), Gaps = 22/188 (11%)
Query: 12 VTLGDYVINSAVEPLPAYTFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPI 71
V LG Y + E TF + ++ + Y PQ + D+ +L+LDR + +
Sbjct: 53 VVLGAYDLRRR-ERQSRQTFSISSMSENGY---DPQQNLNDLMLLQLDREANLTSSVTIL 108
Query: 72 CLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIY 131
LP + + + V+V + QC + G+
Sbjct: 109 PLPLQNATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRPNNVCTGVLT--- 165
Query: 132 DEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTV 191
RGG C GD G PL+ E G+ S +G P + RVA
Sbjct: 166 -------RRGGI---CNGDGGTPLVCE----GLAHGVASFSLGPCGRG-PDFFTRVALFR 210
Query: 192 DWISYIMN 199
DWI ++N
Sbjct: 211 DWIDGVLN 218
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 33.1 bits (74), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 21/49 (42%), Positives = 27/49 (55%), Gaps = 5/49 (10%)
Query: 147 CQGDSGGPLMMERTGRWFLIGIVS-AGYSCAQQGQPGIYHRVAYTVDWI 194
C GDSGGPL+ + + GI S + CA + P + RVA VDWI
Sbjct: 172 CFGDSGGPLICDG----IIQGIDSFVIWGCATRLFPDFFTRVALYVDWI 216
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 31.6 bits (70), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 33/173 (19%)
Query: 39 HPYFKFTPQAD-RYDVAVLRLDRPVQY---------MPHIAPICLPEKGEDXXXXXXXXX 88
H Y F Q D+A+L L RP++ +P I P+ G D
Sbjct: 75 HVYLSFYRQETMENDIAILELSRPLKLDGLKSKPAKLPDIE--FRPKTGSDVLVSGYGDG 132
Query: 89 XXXXXXXXSRLRPKT--LQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDS 146
+ PK L++ + ++D +C + +++ ++ CA G + +S
Sbjct: 133 --------QTMDPKDHDLKSAQLTVVDLDECRTKYGPIFLSLQVF----CAQKVGVSLES 180
Query: 147 CQGDSGGPLMMERTGRWFLIGIVSAGYSCAQQGQPGIYHRVAYTVDWISYIMN 199
GD+G P + + T L+G V+A + +G P ++ +V V WI I+
Sbjct: 181 --GDAGDPTVQQDT----LVG-VAAYFPKRPEGAPEVFTKVGSYVSWIQDIIK 226
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 30.8 bits (68), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 12/37 (32%), Positives = 20/37 (54%)
Query: 43 KFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGED 79
KF R D+ +L+L P Q+ ++ +CLP +D
Sbjct: 75 KFNMFTVRNDITLLKLATPAQFSETVSAVCLPNVDDD 111
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 30.0 bits (66), Expect = 0.87, Method: Compositional matrix adjust.
Identities = 41/170 (24%), Positives = 63/170 (37%), Gaps = 22/170 (12%)
Query: 30 TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXX 89
F V++I + Y P D+ +L+L+ ++ LP +G
Sbjct: 69 VFAVQRIFENGY---DPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAM 125
Query: 90 XXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQG 149
+R LQ ++V ++ + C R SN +C RG C G
Sbjct: 126 GWGLLGRNRGIASVLQELNVTVVTS-LCRR---SN----------VCTLVRGRQAGVCFG 171
Query: 150 DSGGPLMMERTGRWFLIGIVS-AGYSCAQQGQPGIYHRVAYTVDWISYIM 198
DSG PL+ + GI S CA P + VA V+WI I+
Sbjct: 172 DSGSPLVCN----GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSII 217
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 30.0 bits (66), Expect = 0.90, Method: Compositional matrix adjust.
Identities = 41/170 (24%), Positives = 63/170 (37%), Gaps = 22/170 (12%)
Query: 30 TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXX 89
F V++I + Y P D+ +L+L+ ++ LP +G
Sbjct: 69 VFAVQRIFENGY---DPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAM 125
Query: 90 XXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQG 149
+R LQ ++V ++ + C R SN +C RG C G
Sbjct: 126 GWGLLGRNRGIASVLQELNVTVVTS-LCRR---SN----------VCTLVRGRQAGVCFG 171
Query: 150 DSGGPLMMERTGRWFLIGIVS-AGYSCAQQGQPGIYHRVAYTVDWISYIM 198
DSG PL+ + GI S CA P + VA V+WI I+
Sbjct: 172 DSGSPLVCN----GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSII 217
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 29.6 bits (65), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 36/148 (24%), Positives = 55/148 (37%), Gaps = 19/148 (12%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPI 111
D+ +L+L+ ++ LP +G +R LQ ++V +
Sbjct: 88 DIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTV 147
Query: 112 IDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVS- 170
+ + C R SN +C RG C GDSG PL+ + GI S
Sbjct: 148 VTS-LCRR---SN----------VCTLVRGRQAGVCFGDSGSPLVCN----GLIHGIASF 189
Query: 171 AGYSCAQQGQPGIYHRVAYTVDWISYIM 198
CA P + VA V+WI I+
Sbjct: 190 VRGGCASGLYPDAFAPVAQFVNWIDSII 217
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 29.6 bits (65), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 36/148 (24%), Positives = 55/148 (37%), Gaps = 19/148 (12%)
Query: 52 DVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXXXXXXXXXSRLRPKTLQAVDVPI 111
D+ +L+L+ ++ LP +G +R LQ ++V +
Sbjct: 88 DIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAMGWGLLGRNRGIASVLQELNVTV 147
Query: 112 IDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQGDSGGPLMMERTGRWFLIGIVS- 170
+ + C R SN +C RG C GDSG PL+ + GI S
Sbjct: 148 VTS-LCRR---SN----------VCTLVRGRQAGVCFGDSGSPLVCN----GLIHGIASF 189
Query: 171 AGYSCAQQGQPGIYHRVAYTVDWISYIM 198
CA P + VA V+WI I+
Sbjct: 190 VRGGCASGLYPDAFAPVAQFVNWIDSII 217
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 28.1 bits (61), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 40/170 (23%), Positives = 62/170 (36%), Gaps = 22/170 (12%)
Query: 30 TFGVRKINVHPYFKFTPQADRYDVAVLRLDRPVQYMPHIAPICLPEKGEDXXXXXXXXXX 89
F V++I + Y P D+ +L+L+ ++ LP +G
Sbjct: 69 VFAVQRIFENGY---DPVNLLNDIVILQLNGSATINANVQVAQLPAQGRRLGNGVQCLAM 125
Query: 90 XXXXXXXSRLRPKTLQAVDVPIIDNRQCERWHKSNGINVVIYDEMMCAGYRGGAKDSCQG 149
+R LQ ++V ++ + C R SN +C RG C G
Sbjct: 126 GWGLLGRNRGIASVLQELNVTVVTS-LCRR---SN----------VCTLVRGRQAGVCFG 171
Query: 150 DSGGPLMMERTGRWFLIGIVS-AGYSCAQQGQPGIYHRVAYTVDWISYIM 198
D G PL+ + GI S CA P + VA V+WI I+
Sbjct: 172 DXGSPLVCN----GLIHGIASFVRGGCASGLYPDAFAPVAQFVNWIDSII 217
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.322 0.137 0.435
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 5,807,535
Number of Sequences: 62578
Number of extensions: 219747
Number of successful extensions: 1304
Number of sequences better than 100.0: 350
Number of HSP's better than 100.0 without gapping: 315
Number of HSP's successfully gapped in prelim test: 35
Number of HSP's that attempted gapping in prelim test: 453
Number of HSP's gapped (non-prelim): 374
length of query: 203
length of database: 14,973,337
effective HSP length: 94
effective length of query: 109
effective length of database: 9,091,005
effective search space: 990919545
effective search space used: 990919545
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 49 (23.5 bits)